{"id":27,"date":"2015-05-13T12:22:22","date_gmt":"2015-05-13T12:22:22","guid":{"rendered":"http:\/\/www.iths.org\/crecc\/?page_id=27"},"modified":"2025-06-24T10:45:32","modified_gmt":"2025-06-24T17:45:32","slug":"cases","status":"publish","type":"page","link":"https:\/\/www.iths.org\/crecc\/resources-2\/cases\/","title":{"rendered":"Challenging Cases"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text]<\/p>\n<h2>\u00a0Challenging Cases<\/h2>\n<p>[\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text]Established a semi-annual series of \u201cChallenging Cases in Clinical Research Ethics\u201d in the American Journal of Bioethics.[\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_accordion collapsible=&#8221;yes&#8221; style=&#8221;toggle&#8221;][vc_accordion_tab title=&#8221;All Cases&#8221; background_color=&#8221;#ffffff&#8221; title_color=&#8221;#ffffff&#8221;][vc_column_text css=&#8221;&#8221;]<strong>October 2024<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2024.2388741\"><strong>Disclosing Interim Results to Parents Offered Enrollment in a Fetal Intervention Trial.<\/strong><\/a> Ray AD, Dawson L, Wilfond BS, Johnson LM. Am J Bioeth. 2024 Oct;24(10):113-114. doi: 10.1080\/15265161.2024.2388741. Epub 2024 Sep 16. PMID: 39283373.\n<ul>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2024.2388722\">Achieving Live Birth is Not an Endpoint but a Steppingstone.<\/a> Ross LF, Gallo A, Hester DM. Am J Bioeth. 2024 Oct;24(10):115-117. doi: 10.1080\/15265161.2024.2388722. Epub 2024 Sep 16. PMID: 39283371.<\/li>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2024.2388720\">The Role of Perinatal Palliative Care to Support Parental Decision-Making about Clinical Research for Seriously Ill Children in the Neonatal Period.<\/a> Derrington SF. Am J Bioeth. 2024 Oct;24(10):117-119. doi: 10.1080\/15265161.2024.2388720. Epub 2024 Sep 16. PMID: 39283372.<\/li>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2024.2390037\">Atkinson MA, Ezumba E, Miller JL. The Need for an Evolving Informed Consent Process in a Fetal Therapy Trial.<\/a> Am J Bioeth. 2024 Oct;24(10):120-121. doi: 10.1080\/15265161.2024.2390037. Epub 2024 Sep 16. PMID: 39283370; PMCID: PMC11410341.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text css=&#8221;&#8221;]<strong>April 2024<\/strong><\/p>\n<p><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2024.2308155\"><strong>To Swab or Not to Swab: Waiver of Consent to Collect Perianal Specimens from Incapacitated Patients With Severe Burn Injury.<\/strong><\/a> Dawson L, Ray AD, Wilfond BS, Johnson LM. Am J Bioeth. 2024 Apr;24(4):108-109. doi: 10.1080\/15265161.2024.2308155. Epub 2024 Mar 26. PMID: 38529965.<\/p>\n<ul>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2024.2308133\">Ethical Justifications for Waiving Informed Consent for a Perianal Swab in Critical Burn Care Research.<\/a> Earl J, Shupp JW, Krohmal B. Am J Bioeth. 2024 Apr;24(4):110-113. doi: 10.1080\/15265161.2024.2308133. Epub 2024 Mar 26. PMID: 38529966.<\/li>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2024.2308134\">Community Perspectives Are Essential to Assess Risk in Emergent Care Research.<\/a> Chalmeti A, Lesandrini J.\u00a0 Am J Bioeth. 2024 Apr;24(4):113-115. doi: 10.1080\/15265161.2024.2308134. Epub 2024 Mar 26. PMID: 38529967.<\/li>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2024.2308140\">Respect for Persons Is Not Always About Consent: The Importance of Context.<\/a> Dawson L. Am J Bioeth. 2024 Apr;24(4):115-118. doi: 10.1080\/15265161.2024.2308140. Epub 2024 Mar 26. PMID: 38529963.<\/li>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2024.2308145\">The Overlooked Risk of Intimate Violation in Research: No Perianal Sampling Without Consent.<\/a> Gunkel J. Am J Bioeth. 2024 Apr;24(4):118-120. doi: 10.1080\/15265161.2024.2308145. Epub 2024 Mar 26. PMID: 38529968; PMCID: PMC11034838.<\/li>\n<\/ul>\n<p><strong>October 2023<\/strong><\/p>\n<p><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2023.2250275\"><strong>Researcher Obligations to Participants in Novel COVID-19 Vaccine Research.<\/strong><\/a> Wilfond BS, Duenas DM, Johnson LM. Am J Bioeth. 2023 Oct;23(10):119-120. doi: 10.1080\/15265161.2023.2250275. Epub 2023 Oct 9. PMID: 37812093.<\/p>\n<ul>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2023.2250282\">Clinicians Doing Research Should Use Their Clinical Expertise to Help Study Participants.<\/a> Abraham A, Wolf J. Am J Bioeth. 2023 Oct;23(10):121-123. doi: 10.1080\/15265161.2023.2250282. Epub 2023 Oct 9. PMID: 37812120.<\/li>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2023.2250295\">Ancillary Care Obligations of Clinical Trial Investigators in the COVID-19 Pandemic.<\/a> Babu TM, Wald A. Am J Bioeth. 2023 Oct;23(10):123-125. doi: 10.1080\/15265161.2023.2250295. Epub 2023 Oct 9. PMID: 37812103.<\/li>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2023.2250283\">Social Value, Beneficial Information, and Obligations to Participants in a Trial of Novel COVID-19 Vaccines.<\/a> Earl J, Dawson L. Am J Bioeth. 2023 Oct;23(10):126-128. doi: 10.1080\/15265161.2023.2250283. Epub 2023 Oct 9. PMID: 37812119.<\/li>\n<li><a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15265161.2023.2250298\">Ethical Vaccine Recommendations in the Context of Tenuous Data: Honesty is the Best Policy.<\/a> McKinney R. Am J Bioeth. 2023 Oct;23(10):128-130. doi: 10.1080\/15265161.2023.2250298. Epub 2023 Oct 9. PMID: 37812100.<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text]<strong>October 2022<\/strong><\/p>\n<p><strong>To Disclose or Not to Disclose: Secondary Findings of XXY Chromosomes.<\/strong> Wilfond BS, Duenas DM, Johnson LM. Am J Bioeth. 2022 Oct;22(10):87-88. doi: 10.1080\/15265161.2022.2110982. PMID: 36170065.<\/p>\n<ul>\n<li>Miner SA, Hester DM. Respecting Autonomy and Balancing Benefits by Disclosing the Secondary Finding of Klinefelter&#8217;s. Am J Bioeth. 2022 Oct;22(10):89-91. doi: 10.1080\/15265161.2022.2110974. PMID: 36170084.<\/li>\n<li>McGrew S, Berkman BE. When to Disclose a Borderline Incidental Finding. Am J Bioeth. 2022 Oct;22(10):91-93. doi: 10.1080\/15265161.2022.2110975. PMID: 36170085.<\/li>\n<li>Brown J, Howard D. The Importance of Defining Actionability as Related to Disclosure of Secondary Findings Identified in Research. Am J Bioeth. 2022 Oct;22(10):93-95. doi: 10.1080\/15265161.2022.2110976. PMID: 36170082.<\/li>\n<li>Noohi F, Ross LF. Clarifying the Blurry Boundaries between Research and Clinical Care. Am J Bioeth. 2022 Oct;22(10):96-98. doi: 10.1080\/15265161.2022.2110977. PMID: 36170083.<\/li>\n<\/ul>\n<p><strong>April 2022<\/strong><\/p>\n<p><strong>Enrolling Adolescents with Rare Disease for Early Phase Clinical Trials While Under the Care of Child Protection Services: Balancing Protection and Access.<\/strong> Wilfond BS, Duenas DM, Johnson LM. Am J Bioeth. 2022 Apr;22(4):81-82. doi: 10.1080\/15265161.2022.2044552. PMID: 35420512; PMCID: PMC9534357.<\/p>\n<ul>\n<li>Turnbull JM, Benedetti DJ. Fuzzy Logic: How the Practicalities of State Involvement Shape the Most Ethically Supportable Way Forward. Am J Bioeth. 2022 Apr;22(4):83-84. doi: 10.1080\/15265161.2022.2044545. PMID: 35420527.<\/li>\n<li>Greiner MV, Antommaria AHM. Enrolling Foster Youth in Clinical Trials: Avoiding the Harm of Exclusion. Am J Bioeth. 2022 Apr;22(4):85-86. doi: 10.1080\/15265161.2022.2044546. PMID: 35420526.<\/li>\n<li>Forte KJ, Anderson EE. No Justification to Exclude State Ward from Pediatric Transplant Research. Am J Bioeth. 2022 Apr;22(4):87-89. doi: 10.1080\/15265161.2022.2044547. PMID: 35420533.<\/li>\n<li>Sacks H, Rhodes R. Life-Saving Experimental Treatment for a Teenage Ward of the State. Am J Bioeth. 2022 Apr;22(4):89-91. doi: 10.1080\/15265161.2022.2044548. PMID: 35420532.<\/li>\n<\/ul>\n<p><strong>October 2021<\/strong><\/p>\n<p><strong>When Professional Meets Personal: How Should Research Staff Advertise on Social Media for Research Opportunities?<\/strong> Johnson LM, Duenas DM, Wilfond BS. Am J Bioeth. 2021 Oct;21(10):38-39. doi: 10.1080\/15265161.2021.1965251. PMID: 34554059; PMCID: PMC8591987.<\/p>\n<ul>\n<li>Anderson EE. Sharing Research Opportunities on Personal Social Media Accounts and Fair Subject Selection. Am J Bioeth. 2021 Oct;21(10):40-42. doi: 10.1080\/15265161.2021.1965252. PMID: 34554068.<\/li>\n<li>Spellecy R, Nelson LD. How Should Investigators Advertise on Social Media for Research Opportunities? Am J Bioeth. 2021 Oct;21(10):42-43. doi: 10.1080\/15265161.2021.1965254. PMID: 34554066.<\/li>\n<\/ul>\n<p><strong>Supporting Community-Academic Research Partnerships: Reflections from the Ground.<\/strong> Wilfond BS, Duenas DM, Johnson LM. Am J Bioeth. 2021 Oct;21(10):44-45. doi: 10.1080\/15265161.2021.1965255. PMID: 34554061; PMCID: PMC8591989.<\/p>\n<ul>\n<li>Springgate BF, Sugarman O, Wells KB, Palinkas LA, Meyers D, Wennerstrom A, Johnson A, Haywood C, Sarpong D, Culbertson R. Community Partnered Participatory Research in Southeast Louisiana Communities Threatened by Climate Change: The C-LEARN EXPERIENCE. Am J Bioeth. 2021 Oct;21(10):46-48. doi: 10.1080\/15265161.2021.1965248. PMID: 34554077.<\/li>\n<li>Yu JH. Leveraging Academic Institutional Structures to Support Asian American Community Organizations&#8217; Engagement in Research: The Korean Community Service Center. Am J Bioeth. 2021 Oct;21(10):49-51. doi: 10.1080\/15265161.2021.1965253. PMID: 34554067; PMCID: PMC9904358.<\/li>\n<li>Carroll Y. Engaging the Sickle Cell Community in Participatory Research. Am J Bioeth. 2021 Oct;21(10):51-53. doi: 10.1080\/15265161.2021.1965245. PMID: 34554074.<\/li>\n<li>Blanchard J, Hiratsuka V. Being in Good Community: Engagement in Support of Indigenous Sovereignty. Am J Bioeth. 2021 Oct;21(10):54-56. doi: 10.1080\/15265161.2021.1965243. PMID: 34554065; PMCID: PMC9400818.<\/li>\n<\/ul>\n<p><strong>April 2021<\/strong><\/p>\n<p><strong>Supporting Investigators in Challenging Cases: Unease in the Face of an Ethically Appropriate Action.<\/strong> Wilfond BS, Duenas DM, Johnson LM. American Journal of Bioethics. 2021; 21(4):98-99. doi: 10.1080\/15265161.2021.1891342<\/p>\n<ul>\n<li>Schonfeld T, Geppert CMA. Researchers Experience Moral Distress Too! Am J Bioeth. 2021 Apr;21(4):100-101. doi: 10.1080\/15265161.2021.1891327. PMID: 33825626.<\/li>\n<li>Blee S, Sibold HC, Dixon M, Pentz RD. Relieving Investigator Angst After an Appropriate But Concerning Ethics Consultation. Am J Bioeth. 2021 Apr;21(4):102-104. doi: 10.1080\/15265161.2021.1891329. PMID: 33825637.<\/li>\n<li>Spellecy R, Nyitray A. Acknowledging Angst: Research Ethics Consultation in Disclosing Experimental Research Results of Uncertain Benefit. Am J Bioeth. 2021 Apr;21(4):104-105. doi: 10.1080\/15265161.2021.1891331. PMID: 33825651.<\/li>\n<\/ul>\n<p><strong>Conjoined Consent: Informed Consent When Donor and Recipient Are Both Research Participants.<\/strong> Johnson LM, Duenas DM, Wilfond BS. Am J Bioeth. 2021 Apr;21(4):106-107. doi: 10.1080\/15265161.2021.1891343. PMID: 33825622; PMCID: PMC8607986.<\/p>\n<ul>\n<li>Aaron B, Ginsberg J, Lesandrini J. Moving Beyond Standard Informed Consent for Interventional Organ Transplant Research. Am J Bioeth. 2021 Apr;21(4):108-110. doi: 10.1080\/15265161.2021.1891328. PMID: 33825627.<\/li>\n<li>Ghobrial P, Akkina S, Anderson EE. Risks to Relationships in Kidney Transplant Research with Living Donors and Recipients. Am J Bioeth. 2021 Apr;21(4):110-112. doi: 10.1080\/15265161.2021.1891330. PMID: 33825649.<\/li>\n<li>Kraft SA. Respecting Donor-Recipient Relationships in Research Decision-Making Commentary on: When Living Donor and Kidney Transplant Recipient Are Both Research Subjects. Am J Bioeth. 2021 Apr;21(4):112-114. doi: 10.1080\/15265161.2021.1891326. PMID: 33825630.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>October 2020<br \/>\n<\/strong><\/p>\n<p><strong>Click Here to Complete This Survey: Online Research, Adolescents, and Parental Consent<\/strong><br \/>\nJohnson LM, Duenas DM, Wilfond BS. American Journal of Bioethics 2020; 20(10): 82-83. DOI: 10.1080\/15265161.2020.1806381<\/p>\n<ul>\n<li>Digital Negotiations: Navigating Parental Permission and Adolescent Assent for On-Line Survey Participation<br \/>\nTaylor HA and Mogul DB. American Journal of Bioethics 2020; 20(10): 84-85. DOI: 10.1080\/15265161.2020.1806375<\/li>\n<li>Constrained Adolescent Autonomy for Healthcare Should Include Participation in Survey Research<br \/>\nCaruso Brown AE. American Journal of Bioethics 2020; 20(10): 85-87. DOI: 10.1080\/15265161.2020.1806377<\/li>\n<li>Respecting Parental Permission and Maintaining Flexibility in Online Research Involving Adolescent Participants<br \/>\nKnapp EE. American Journal of Bioethics 2020; 20(10): 87-89. DOI: 10.1080\/15265161.2020.1806390<\/li>\n<\/ul>\n<p><strong>Conflicts of Interest and Recommendations for Clinical Treatments That Benefit Researchers<\/strong><br \/>\nWilfond BS, Duenas DM, Johnson LM. American Journal of Bioethics 2020; 20(10): 90-91. DOI: 10.1080\/15265161.2020.1806380<\/p>\n<ul>\n<li>Not All Conflicts Are Bad: Why Some Conflicts of Interests Advance Patients\u2019 Interests<br \/>\nBenedetti DJ and Langerman A. American Journal of Bioethics 2020; 20(10): 92-94. DOI: 10.1080\/15265161.2020.1806626<\/li>\n<li>Inherent Conflict of Interest in Clinical Research: A Call for Effective Guidance<br \/>\nNicolini ME and Wendler D. American Journal of Bioethics 2020; 20(10): 94-96. DOI: 10.1080\/15265161.2020.1806376<\/li>\n<li>A Therapeutic Conundrum: Should a Physician Serve Simultaneously as Caregiver and Researcher?<br \/>\nHutchinson RJ. American Journal of Bioethics 2020; 20(10): 96-98. DOI: 10.1080\/15265161.2020.1806378<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>April 2020<\/strong><\/p>\n<p><strong>Ethical Drug Development for Rare Childhood Diseases: When There are Limited but Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?<\/strong><br \/>\nJohnson LM, Duenas DM, Wilfond BS. American Journal of Bioethics 2020; 20(4): 111-113. DOI: 10.1080\/15265161.2020.1730490<\/p>\n<ul>\n<li>The Use of Pediatric Extrapolation to Avoid Unnecessary Pediatric Clinical Trials.<br \/>\nNelson R. American Journal of Bioethics 2020; 20(4): 114-116. DOI: 10.1080\/15265161.2020.1730489<\/li>\n<li>Flexibility Required: Balancing the Interests of Children and Risk in Drug Development for Rare Pediatric Conditions.<br \/>\nPorter KM, Stevens A, Wilfond BS. American Journal of Bioethics 2020; 20(4): 116-118. DOI: 10.1080\/15265161.2020.1730494<\/li>\n<li>When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.<br \/>\nMastler J and Young J. American Journal of Bioethics 2020; 20(4): 118-120. DOI: 10.1080\/15265161.2020.1730491<\/li>\n<\/ul>\n<p><strong>Greater than Minimal Risk, No Direct Benefit \u2013 Bridging Drug Trials and Novel Therapy in Pediatric Populations.<\/strong><br \/>\nWilfond BS, Duenas DM, Johnson LM. American Journal of Bioethics 2020; 20(4): 102-103. DOI: 10.1080\/15265161.2020.1730488<\/p>\n<ul>\n<li>Balancing Risk and Reward: Research with Novel Therapies for Children with Life-limiting Illness.<br \/>\nUnguru Y. American Journal of Bioethics 2020; 20(4): 104-105. DOI: 10.1080\/15265161.2020.1730484<\/li>\n<li>Bringing Known Drugs to Pediatric Research \u2013 Safety, Efficacy, and the Ambiguous Minor Increase in Minimal Risk.<br \/>\nSharma A and Johnson LM. American Journal of Bioethics 2020; 20(4): 106-108. DOI: 10.1080\/15265161.2020.1730485<\/li>\n<li>Balancing Scientific Progress with Pediatric Protections: No Direct Benefit Now, but Potential Novel Therapy in the Future.<br \/>\nLee SW and Ginsberg JC. American Journal of Bioethics 2020; 20(4): 108-110. DOI: 10.1080\/15265161.2020.1730486<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>October 2019<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654024\">A Pragmatic Trial of Suicide Risk Assessment and Ambulance Transport Decision Making Among Emergency Medical Services Providers: Implications for Patient Consent.<\/a><\/strong><br \/>\nWilfond BS, Zambrowski J, Johnson LM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 97-98.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654017\">Improving Care for Suicidal Patients While Protecting Human Subjects: Addressing Ethical Challenges in Mental Health Research Involving Emergency Medical Services Providers.<\/a><br \/>\nDeCou CR, Shah SK, Porter KM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 99-101.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654013\">A Stepwise Approach to Ethically Assess Pragmatic Cluster Randomized Trials: Implications for Informed Consent for Suicide Prevention Implementation Research.<\/a><br \/>\nGoldstein CE and Weijer C. <em>American Journal of Bioethics<\/em> 2019; 19(10): 101-103.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654014\">Informed Consent in a Pragmatic Emergency Suicide Trial: Rejecting the Research\u2013Practice Distinction.<\/a><br \/>\nCanavera K and Parris K. <em>American Journal of Bioethics<\/em> 2019; 19(10): 103-105.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654020\">A Pragmatic Trial for Emergency Medical Service Providers\u2019 Prehospital Response to Suidality: Consent Is Not Essential, but Limited Patient Engagement May Be Meaningful.<\/a><br \/>\nDickert NW. <em>American Journal of Bioethics<\/em> 2019; 19(10): 105-107.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654032\">A Cluster Randomized Trial to Screen for Abusive Head Trauma in the Pediatric Intensive Care Unit\u2014How to Manage Site-Specific Evidence of Racial\/Ethic Disparity.<\/a><\/strong><br \/>\nJohnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 108-109.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654012\">Issues of Justice and Risk: Setting Stopping Criteria in Cluster-Randomized Trials.<\/a><br \/>\nTumilty E and Farroni JS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 110-111.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654015\">Clinical Trials Not Causing Harm With Potential for Realizing Benefit Should Continue.<\/a><br \/>\nJackson BM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 112-114.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654030\">Responding to Implicit Bias in Abusive Head Trauma Evaluations and Reporting in the PICU: Ethical Consideration During a Clinical Trial.<\/a><br \/>\nMcCormick JB and Hymel KP. <em>American Journal of Bioethics<\/em> 2019; 19(10): 114-115.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>April 2019<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572831\">Should Research Participants Be Notified About Results of Currently Unknown by Potential Significance?<\/a><\/strong><br \/>\nJohnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(4): 73-74.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572825\">The Need For National Guidance Around Informed Consent About GBCA Safety.<\/a><br \/>\nBrown SB. <em>American Journal of Bioethics<\/em> 2019; 19(4): 75-77.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572829\">Returning Individual Research Results Regarding Gadolinium Deposition in the Brain Is the Preferable Choice.<\/a><br \/>\nHuang CJ, Bandettini WP, Danis M. <em>American Journal of Bioethics<\/em> 2019; 19(4): 77-78.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572830\">Research Participants Should Have the Option to Be Notified of Results of Unknown but Potential Significance.<\/a><br \/>\nHutchinson N, Capron A, Doussau A. <em>American Journal of Bioethics<\/em> 2019; 19(4): 78-80.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572832\">The Limitation of &#8220;Boilerplate&#8221; Language in Informed Consent: Single IRB Review of Multisite Genetic Research in Military Personnel.<\/a><\/strong><br \/>\nWilfond BS, Zambrowski J, Johnson LM. <em>American Journal of Bioethics<\/em> 2019; 19(4): 81-82.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572827\">The Bane of &#8220;Boilerplate&#8221; Language in Research Consent Forms: Ensuring Consent Forms Promote Autonomous Authorization.<\/a><br \/>\nBotkin JR. <em>American Journal of Bioethics<\/em> 2019; 19(4): 83-84.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572828\">Single IRBs Are Responsible to Ensure Consent Language Effectively Conveys the Local Context.<\/a><br \/>\nHull SC and Schiffenbauer AI. <em>American Journal of Bioethics<\/em> 2019; 19(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572826\">Solving the Single IRB\/Boilerplate Bind: Establishing Institutional Guidelines.<\/a><br \/>\nAbraham ME, Hohmann E, Morash M. <em>American Journal of Bioethics<\/em> 2019; 19(4): 87-88.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>October 2018<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1522166\">A Randomized Trial of Rapamycin to Increase Longevity and Healthspan in Companion Animals: Navigating the Boundary Between Protections for Animal Research and Human Subjects Research.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Johnson LM, Wilfond BS. <em>American Journal of Bioethics<\/em> 2018; 18(10): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513586\">Rapamycin: Risking Harm for Canine Longevity.<\/a><br \/>\nAbbate C. <em>American Journal of Bioethics<\/em> 2018; 18(10): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513587\">Companion Animal Studies: Slipping Through a Research Oversight Gap.<\/a><br \/>\nWalker RL and Fisher JA. <em>American Journal of Bioethics<\/em> 2018; 18(10): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513591\">Research to Promote Longevity and Health Span in Companion Dogs: A Pediatric Perspective.<\/a><br \/>\nWilfond BS, Porter KM, Creevy KE, Kaerberlein M, Promislow D. <em>American Journal of Bioethics<\/em> 2018; 18(10): 64-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1522167\">Ethical Considerations for Unblinding a Participant\u2019s Assignment to Interpret a Resolved Adverse Event.<\/a><\/strong><br \/>\nWilfond BS, Morales C, Johnson LM, Taylor HA. <em>American Journal of Bioethics<\/em> 2018; 18(10): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513588\">Considerations for Unblinding in Biopharmaceutical Industry Sponsored Trials.<\/a><br \/>\nShah JJ and Bond J. <em>American Journal of Bioethics<\/em> 2018; 18(10): 68-70.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513590\">Blinds and Research Risks.<\/a><br \/>\nSteel R and Danis M. <em>American Journal of Bioethics<\/em> 2018; 18(10): 70-71.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513589\">The Scientific and Social Implications of Unblinding a Study Subject.<\/a><br \/>\nQuittell LM. <em>American Journal of Bioethics<\/em> 2018; 18(10): 71-73.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>April 2018<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1433796\">Is It Ethically Appropriate to Refuse to Compensate Participants Who Are Believed to Have Intentionally Concealed Medical Conditions?<\/a><br \/>\n<\/strong>Taylor HA and Morales C. <em>American Journal of Bioethics<\/em> 2018; 18(4): 83-84.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431703\">Mutual Obligations in Research and Withholding Payment From Deceptive Participants.<\/a><br \/>\nFernandez Lynch H, Gelinas L, Largent EA. <em>American Journal of Bioethics<\/em> 2018; 18(4): 85-87.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431707\">Best to Exclude but Pay.<\/a><br \/>\nDanis M, Doernberg S, Memoli M, Millum J. <em>American Journal of Bioethics<\/em> 2018; 18(4): 87-88.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431720\">To Pay or Not to Pay? Withholding Payment From Research Participants.<\/a><br \/>\nRhodes R and Danziger M. <em>American Journal of Bioethics<\/em> 2018; 18(4): 88-90.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1433798\">Involving Pregnant Women in Research: What Should We Recommend When the Regulations Seem Ethically Problematic?<\/a><\/strong><br \/>\nTaylor HA and Morales C. <em>American Journal of Bioethics<\/em> 2018; 18(4): 91-92.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431704\">Conflicts Between Regulations and Ethical Principles: Resolving Ambiguity in Favor of the Ethically Preferable Outcome.<\/a><br \/>\nShah SK and Porter K. <em>American Journal of Bioethics<\/em> 2018; 18(4): 93-94.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431721\">When to Avoid Giving Advice on the Ethical Conduct of Research.<\/a><br \/>\nSharp RR and Allyse MA. <em>American Journal of Bioethics<\/em> 2018; 18(4): 94-95.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431706\">When Research Regulations and Ethics Conflict.<\/a><br \/>\nSullivan HK, Braverman DW, Wendler D. <em>American Journal of Bioethics<\/em> 2018; 18(4): 96-97.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>October 2017<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1366199\">Expanded Access for Nusinersen in Patients With Spinal Muscular Atropy: Negotiating Limited Data, Limited Alternative Treatments, and Limited Hospital Resources.<\/a><br \/>\n<\/strong>Wilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(10): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365197\">Hard Choices for Vulnerable Patients: Some Lessons Learned That May Apply.<\/a><br \/>\nKearns L and Caplan AL. <em>American Journal of Bioethics<\/em> 2017; 17(10): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365196\">Is There a \u2018Right to Try\u2019 Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.<\/a><br \/>\nJecker NS. <em>American Journal of Bioethics<\/em> 2017; 17(10): 70-71.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365198\">Fairness and Transparency in an Expanded Access Program: Allocation of the Only Treatment for SMA1.<\/a><br \/>\nBurgart AM, Collier J, Cho MK. <em>American Journal of Bioethics<\/em> 2017; 17(10): 71-73.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1366200\">A Trial to Test a Novel Approach to Diabetes Prevention.<\/a><\/strong><br \/>\nTaylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(10): 74-75.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365201\">Is It Ethically Acceptable to Screen Patients for Obstructive Sleep Apnea and Not Offer Them Positive Air Pressure Therapy in a Clinical Trial?<\/a><br \/>\nMcCormick JB, Wu JT, Doussau A. <em>American Journal of Bioethics<\/em> 2017; 17(10): 76-77.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365199\">Can We Breathe Easy If PAP Therapy Is Withheld?<\/a><br \/>\nTaylor HA and Punjabi NM. <em>American Journal of Bioethics<\/em> 2017; 17(10): 78-79.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365200\">Risks of Clinical Research Must Be Reasonable and Necessary.<\/a><br \/>\nGibbes Miller D and Kim SYH. <em>American Journal of Bioethics<\/em> 2017; 17(10): 79-81.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>April 2017<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284935\">Genotype-Driven Recruitment in Population-Based Biomedical Research.<\/a><\/strong><br \/>\nTaylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(4): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284924\">Genotype-Driven Recruitment Without Deception.<\/a><br \/>\nOssorio P and Mailick M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284920\">Harms of Deception in FMR1 Premutation Genotype-Driven Recruitment.<\/a><br \/>\nDoernberg S and Hull SC. <em>American Journal of Bioethics<\/em> 2017; 17(4): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284916\">Genotype-Driven Recruitment and the Disclosure of Individual Research Results.<\/a><br \/>\nBeskow LM. <em>American Journal of Bioethics<\/em> 2017; 17(4): 64-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284934\">Should Patients Be Required to Undergo Standard Chemotherapy Before Being Eligible for Novel Phase I Immunotherapy Clinical Trials?<\/a><\/strong><br \/>\nWilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(4): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284922\">A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.<\/a><br \/>\nDoussau A and Hanmer CB. <em>American Journal of Bioethics<\/em> 2017; 17(4): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284933\">Participation of Citizen Scientists in Clinical Research and Access to Research Ethics Consultation.<\/a><br \/>\nCollier E and Danis M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 70-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284936\">Forgoing Conventional Therapy in Phase I Oncology Research: Don&#8217;t Forget About the Children.<\/a><br \/>\nWetmore C. <em>American Journal of Bioethics<\/em> 2017; 17(4): 72-73<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text css=&#8221;&#8221;]<strong>October 2022<\/strong><\/p>\n<p><strong>To Disclose or Not to Disclose: Secondary Findings of XXY Chromosomes.<\/strong> Wilfond BS, Duenas DM, Johnson LM. Am J Bioeth. 2022 Oct;22(10):87-88. doi: 10.1080\/15265161.2022.2110982. PMID: 36170065.<\/p>\n<ul>\n<li>Miner SA, Hester DM. Respecting Autonomy and Balancing Benefits by Disclosing the Secondary Finding of Klinefelter&#8217;s. Am J Bioeth. 2022 Oct;22(10):89-91. doi: 10.1080\/15265161.2022.2110974. PMID: 36170084.<\/li>\n<li>McGrew S, Berkman BE. When to Disclose a Borderline Incidental Finding. Am J Bioeth. 2022 Oct;22(10):91-93. doi: 10.1080\/15265161.2022.2110975. PMID: 36170085.<\/li>\n<li>Brown J, Howard D. The Importance of Defining Actionability as Related to Disclosure of Secondary Findings Identified in Research. Am J Bioeth. 2022 Oct;22(10):93-95. doi: 10.1080\/15265161.2022.2110976. PMID: 36170082.<\/li>\n<li>Noohi F, Ross LF. Clarifying the Blurry Boundaries between Research and Clinical Care. Am J Bioeth. 2022 Oct;22(10):96-98. doi: 10.1080\/15265161.2022.2110977. PMID: 36170083.<\/li>\n<\/ul>\n<p><strong>April 2022<\/strong><\/p>\n<p><strong>Enrolling Adolescents with Rare Disease for Early Phase Clinical Trials While Under the Care of Child Protection Services: Balancing Protection and Access.<\/strong> Wilfond BS, Duenas DM, Johnson LM. Am J Bioeth. 2022 Apr;22(4):81-82. doi: 10.1080\/15265161.2022.2044552. PMID: 35420512; PMCID: PMC9534357.<\/p>\n<ul>\n<li>Turnbull JM, Benedetti DJ. Fuzzy Logic: How the Practicalities of State Involvement Shape the Most Ethically Supportable Way Forward. Am J Bioeth. 2022 Apr;22(4):83-84. doi: 10.1080\/15265161.2022.2044545. PMID: 35420527.<\/li>\n<li>Greiner MV, Antommaria AHM. Enrolling Foster Youth in Clinical Trials: Avoiding the Harm of Exclusion. Am J Bioeth. 2022 Apr;22(4):85-86. doi: 10.1080\/15265161.2022.2044546. PMID: 35420526.<\/li>\n<li>Forte KJ, Anderson EE. No Justification to Exclude State Ward from Pediatric Transplant Research. Am J Bioeth. 2022 Apr;22(4):87-89. doi: 10.1080\/15265161.2022.2044547. PMID: 35420533.<\/li>\n<li>Sacks H, Rhodes R. Life-Saving Experimental Treatment for a Teenage Ward of the State. Am J Bioeth. 2022 Apr;22(4):89-91. doi: 10.1080\/15265161.2022.2044548. PMID: 35420532.<\/li>\n<\/ul>\n<p><strong>October 2021<\/strong><\/p>\n<p><strong>When Professional Meets Personal: How Should Research Staff Advertise on Social Media for Research Opportunities?<\/strong> Johnson LM, Duenas DM, Wilfond BS. Am J Bioeth. 2021 Oct;21(10):38-39. doi: 10.1080\/15265161.2021.1965251. PMID: 34554059; PMCID: PMC8591987.<\/p>\n<ul>\n<li>Anderson EE. Sharing Research Opportunities on Personal Social Media Accounts and Fair Subject Selection. Am J Bioeth. 2021 Oct;21(10):40-42. doi: 10.1080\/15265161.2021.1965252. PMID: 34554068.<\/li>\n<li>Spellecy R, Nelson LD. How Should Investigators Advertise on Social Media for Research Opportunities? Am J Bioeth. 2021 Oct;21(10):42-43. doi: 10.1080\/15265161.2021.1965254. PMID: 34554066.<\/li>\n<\/ul>\n<p><strong>Supporting Community-Academic Research Partnerships: Reflections from the Ground.<\/strong> Wilfond BS, Duenas DM, Johnson LM. Am J Bioeth. 2021 Oct;21(10):44-45. doi: 10.1080\/15265161.2021.1965255. PMID: 34554061; PMCID: PMC8591989.<\/p>\n<ul>\n<li>Springgate BF, Sugarman O, Wells KB, Palinkas LA, Meyers D, Wennerstrom A, Johnson A, Haywood C, Sarpong D, Culbertson R. Community Partnered Participatory Research in Southeast Louisiana Communities Threatened by Climate Change: The C-LEARN EXPERIENCE. Am J Bioeth. 2021 Oct;21(10):46-48. doi: 10.1080\/15265161.2021.1965248. PMID: 34554077.<\/li>\n<li>Yu JH. Leveraging Academic Institutional Structures to Support Asian American Community Organizations&#8217; Engagement in Research: The Korean Community Service Center. Am J Bioeth. 2021 Oct;21(10):49-51. doi: 10.1080\/15265161.2021.1965253. PMID: 34554067; PMCID: PMC9904358.<\/li>\n<li>Carroll Y. Engaging the Sickle Cell Community in Participatory Research. Am J Bioeth. 2021 Oct;21(10):51-53. doi: 10.1080\/15265161.2021.1965245. PMID: 34554074.<\/li>\n<li>Blanchard J, Hiratsuka V. Being in Good Community: Engagement in Support of Indigenous Sovereignty. Am J Bioeth. 2021 Oct;21(10):54-56. doi: 10.1080\/15265161.2021.1965243. PMID: 34554065; PMCID: PMC9400818.<\/li>\n<\/ul>\n<p><strong>April 2021<\/strong><\/p>\n<p><strong>Supporting Investigators in Challenging Cases: Unease in the Face of an Ethically Appropriate Action.<\/strong> Wilfond BS, Duenas DM, Johnson LM. American Journal of Bioethics. 2021; 21(4):98-99. doi: 10.1080\/15265161.2021.1891342<\/p>\n<ul>\n<li>Schonfeld T, Geppert CMA. Researchers Experience Moral Distress Too! Am J Bioeth. 2021 Apr;21(4):100-101. doi: 10.1080\/15265161.2021.1891327. PMID: 33825626.<\/li>\n<li>Blee S, Sibold HC, Dixon M, Pentz RD. Relieving Investigator Angst After an Appropriate But Concerning Ethics Consultation. Am J Bioeth. 2021 Apr;21(4):102-104. doi: 10.1080\/15265161.2021.1891329. PMID: 33825637.<\/li>\n<li>Spellecy R, Nyitray A. Acknowledging Angst: Research Ethics Consultation in Disclosing Experimental Research Results of Uncertain Benefit. Am J Bioeth. 2021 Apr;21(4):104-105. doi: 10.1080\/15265161.2021.1891331. PMID: 33825651.<\/li>\n<\/ul>\n<p><strong>Conjoined Consent: Informed Consent When Donor and Recipient Are Both Research Participants.<\/strong> Johnson LM, Duenas DM, Wilfond BS. Am J Bioeth. 2021 Apr;21(4):106-107. doi: 10.1080\/15265161.2021.1891343. PMID: 33825622; PMCID: PMC8607986.<\/p>\n<ul>\n<li>Aaron B, Ginsberg J, Lesandrini J. Moving Beyond Standard Informed Consent for Interventional Organ Transplant Research. Am J Bioeth. 2021 Apr;21(4):108-110. doi: 10.1080\/15265161.2021.1891328. PMID: 33825627.<\/li>\n<li>Ghobrial P, Akkina S, Anderson EE. Risks to Relationships in Kidney Transplant Research with Living Donors and Recipients. Am J Bioeth. 2021 Apr;21(4):110-112. doi: 10.1080\/15265161.2021.1891330. PMID: 33825649.<\/li>\n<li>Kraft SA. Respecting Donor-Recipient Relationships in Research Decision-Making Commentary on: When Living Donor and Kidney Transplant Recipient Are Both Research Subjects. Am J Bioeth. 2021 Apr;21(4):112-114. doi: 10.1080\/15265161.2021.1891326. PMID: 33825630.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>October 2020<br \/>\n<\/strong><\/p>\n<p><strong>Click Here to Complete This Survey: Online Research, Adolescents, and Parental Consent<\/strong><br \/>\nJohnson LM, Duenas DM, Wilfond BS. American Journal of Bioethics 2020; 20(10): 82-83. DOI: 10.1080\/15265161.2020.1806381<\/p>\n<ul>\n<li>Digital Negotiations: Navigating Parental Permission and Adolescent Assent for On-Line Survey Participation<br \/>\nTaylor HA and Mogul DB. American Journal of Bioethics 2020; 20(10): 84-85. DOI: 10.1080\/15265161.2020.1806375<\/li>\n<li>Constrained Adolescent Autonomy for Healthcare Should Include Participation in Survey Research<br \/>\nCaruso Brown AE. American Journal of Bioethics 2020; 20(10): 85-87. DOI: 10.1080\/15265161.2020.1806377<\/li>\n<li>Respecting Parental Permission and Maintaining Flexibility in Online Research Involving Adolescent Participants<br \/>\nKnapp EE. American Journal of Bioethics 2020; 20(10): 87-89. DOI: 10.1080\/15265161.2020.1806390<\/li>\n<\/ul>\n<p><strong>Conflicts of Interest and Recommendations for Clinical Treatments That Benefit Researchers<\/strong><br \/>\nWilfond BS, Duenas DM, Johnson LM. American Journal of Bioethics 2020; 20(10): 90-91. DOI: 10.1080\/15265161.2020.1806380<\/p>\n<ul>\n<li>Not All Conflicts Are Bad: Why Some Conflicts of Interests Advance Patients\u2019 Interests<br \/>\nBenedetti DJ and Langerman A. American Journal of Bioethics 2020; 20(10): 92-94. DOI: 10.1080\/15265161.2020.1806626<\/li>\n<li>Inherent Conflict of Interest in Clinical Research: A Call for Effective Guidance<br \/>\nNicolini ME and Wendler D. American Journal of Bioethics 2020; 20(10): 94-96. DOI: 10.1080\/15265161.2020.1806376<\/li>\n<li>A Therapeutic Conundrum: Should a Physician Serve Simultaneously as Caregiver and Researcher?<br \/>\nHutchinson RJ. American Journal of Bioethics 2020; 20(10): 96-98. DOI: 10.1080\/15265161.2020.1806378<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>April 2020<\/strong><\/p>\n<p><strong>Ethical Drug Development for Rare Childhood Diseases: When There are Limited but Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?<\/strong><br \/>\nJohnson LM, Duenas DM, Wilfond BS. American Journal of Bioethics 2020; 20(4): 111-113. DOI: 10.1080\/15265161.2020.1730490<\/p>\n<ul>\n<li>The Use of Pediatric Extrapolation to Avoid Unnecessary Pediatric Clinical Trials.<br \/>\nNelson R. American Journal of Bioethics 2020; 20(4): 114-116. DOI: 10.1080\/15265161.2020.1730489<\/li>\n<li>Flexibility Required: Balancing the Interests of Children and Risk in Drug Development for Rare Pediatric Conditions.<br \/>\nPorter KM, Stevens A, Wilfond BS. American Journal of Bioethics 2020; 20(4): 116-118. DOI: 10.1080\/15265161.2020.1730494<\/li>\n<li>When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.<br \/>\nMastler J and Young J. American Journal of Bioethics 2020; 20(4): 118-120. DOI: 10.1080\/15265161.2020.1730491<\/li>\n<\/ul>\n<p><strong>Greater than Minimal Risk, No Direct Benefit \u2013 Bridging Drug Trials and Novel Therapy in Pediatric Populations.<\/strong><br \/>\nWilfond BS, Duenas DM, Johnson LM. American Journal of Bioethics 2020; 20(4): 102-103. DOI: 10.1080\/15265161.2020.1730488<\/p>\n<ul>\n<li>Balancing Risk and Reward: Research with Novel Therapies for Children with Life-limiting Illness.<br \/>\nUnguru Y. American Journal of Bioethics 2020; 20(4): 104-105. DOI: 10.1080\/15265161.2020.1730484<\/li>\n<li>Bringing Known Drugs to Pediatric Research \u2013 Safety, Efficacy, and the Ambiguous Minor Increase in Minimal Risk.<br \/>\nSharma A and Johnson LM. American Journal of Bioethics 2020; 20(4): 106-108. DOI: 10.1080\/15265161.2020.1730485<\/li>\n<li>Balancing Scientific Progress with Pediatric Protections: No Direct Benefit Now, but Potential Novel Therapy in the Future.<br \/>\nLee SW and Ginsberg JC. American Journal of Bioethics 2020; 20(4): 108-110. DOI: 10.1080\/15265161.2020.1730486<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>October 2019<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654024\">A Pragmatic Trial of Suicide Risk Assessment and Ambulance Transport Decision Making Among Emergency Medical Services Providers: Implications for Patient Consent.<\/a><\/strong><br \/>\nWilfond BS, Zambrowski J, Johnson LM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 97-98.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654017\">Improving Care for Suicidal Patients While Protecting Human Subjects: Addressing Ethical Challenges in Mental Health Research Involving Emergency Medical Services Providers.<\/a><br \/>\nDeCou CR, Shah SK, Porter KM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 99-101.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654013\">A Stepwise Approach to Ethically Assess Pragmatic Cluster Randomized Trials: Implications for Informed Consent for Suicide Prevention Implementation Research.<\/a><br \/>\nGoldstein CE and Weijer C. <em>American Journal of Bioethics<\/em> 2019; 19(10): 101-103.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654014\">Informed Consent in a Pragmatic Emergency Suicide Trial: Rejecting the Research\u2013Practice Distinction.<\/a><br \/>\nCanavera K and Parris K. <em>American Journal of Bioethics<\/em> 2019; 19(10): 103-105.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654020\">A Pragmatic Trial for Emergency Medical Service Providers\u2019 Prehospital Response to Suidality: Consent Is Not Essential, but Limited Patient Engagement May Be Meaningful.<\/a><br \/>\nDickert NW. <em>American Journal of Bioethics<\/em> 2019; 19(10): 105-107.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654032\">A Cluster Randomized Trial to Screen for Abusive Head Trauma in the Pediatric Intensive Care Unit\u2014How to Manage Site-Specific Evidence of Racial\/Ethic Disparity.<\/a><\/strong><br \/>\nJohnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 108-109.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654012\">Issues of Justice and Risk: Setting Stopping Criteria in Cluster-Randomized Trials.<\/a><br \/>\nTumilty E and Farroni JS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 110-111.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654015\">Clinical Trials Not Causing Harm With Potential for Realizing Benefit Should Continue.<\/a><br \/>\nJackson BM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 112-114.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654030\">Responding to Implicit Bias in Abusive Head Trauma Evaluations and Reporting in the PICU: Ethical Consideration During a Clinical Trial.<\/a><br \/>\nMcCormick JB and Hymel KP. <em>American Journal of Bioethics<\/em> 2019; 19(10): 114-115.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>April 2019<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572831\">Should Research Participants Be Notified About Results of Currently Unknown by Potential Significance?<\/a><\/strong><br \/>\nJohnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(4): 73-74.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572825\">The Need For National Guidance Around Informed Consent About GBCA Safety.<\/a><br \/>\nBrown SB. <em>American Journal of Bioethics<\/em> 2019; 19(4): 75-77.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572829\">Returning Individual Research Results Regarding Gadolinium Deposition in the Brain Is the Preferable Choice.<\/a><br \/>\nHuang CJ, Bandettini WP, Danis M. <em>American Journal of Bioethics<\/em> 2019; 19(4): 77-78.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572830\">Research Participants Should Have the Option to Be Notified of Results of Unknown but Potential Significance.<\/a><br \/>\nHutchinson N, Capron A, Doussau A. <em>American Journal of Bioethics<\/em> 2019; 19(4): 78-80.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572832\">The Limitation of &#8220;Boilerplate&#8221; Language in Informed Consent: Single IRB Review of Multisite Genetic Research in Military Personnel.<\/a><\/strong><br \/>\nWilfond BS, Zambrowski J, Johnson LM. <em>American Journal of Bioethics<\/em> 2019; 19(4): 81-82.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572827\">The Bane of &#8220;Boilerplate&#8221; Language in Research Consent Forms: Ensuring Consent Forms Promote Autonomous Authorization.<\/a><br \/>\nBotkin JR. <em>American Journal of Bioethics<\/em> 2019; 19(4): 83-84.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572828\">Single IRBs Are Responsible to Ensure Consent Language Effectively Conveys the Local Context.<\/a><br \/>\nHull SC and Schiffenbauer AI. <em>American Journal of Bioethics<\/em> 2019; 19(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572826\">Solving the Single IRB\/Boilerplate Bind: Establishing Institutional Guidelines.<\/a><br \/>\nAbraham ME, Hohmann E, Morash M. <em>American Journal of Bioethics<\/em> 2019; 19(4): 87-88.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>October 2018<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1522166\">A Randomized Trial of Rapamycin to Increase Longevity and Healthspan in Companion Animals: Navigating the Boundary Between Protections for Animal Research and Human Subjects Research.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Johnson LM, Wilfond BS. <em>American Journal of Bioethics<\/em> 2018; 18(10): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513586\">Rapamycin: Risking Harm for Canine Longevity.<\/a><br \/>\nAbbate C. <em>American Journal of Bioethics<\/em> 2018; 18(10): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513587\">Companion Animal Studies: Slipping Through a Research Oversight Gap.<\/a><br \/>\nWalker RL and Fisher JA. <em>American Journal of Bioethics<\/em> 2018; 18(10): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513591\">Research to Promote Longevity and Health Span in Companion Dogs: A Pediatric Perspective.<\/a><br \/>\nWilfond BS, Porter KM, Creevy KE, Kaerberlein M, Promislow D. <em>American Journal of Bioethics<\/em> 2018; 18(10): 64-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1522167\">Ethical Considerations for Unblinding a Participant\u2019s Assignment to Interpret a Resolved Adverse Event.<\/a><\/strong><br \/>\nWilfond BS, Morales C, Johnson LM, Taylor HA. <em>American Journal of Bioethics<\/em> 2018; 18(10): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513588\">Considerations for Unblinding in Biopharmaceutical Industry Sponsored Trials.<\/a><br \/>\nShah JJ and Bond J. <em>American Journal of Bioethics<\/em> 2018; 18(10): 68-70.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513590\">Blinds and Research Risks.<\/a><br \/>\nSteel R and Danis M. <em>American Journal of Bioethics<\/em> 2018; 18(10): 70-71.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513589\">The Scientific and Social Implications of Unblinding a Study Subject.<\/a><br \/>\nQuittell LM. <em>American Journal of Bioethics<\/em> 2018; 18(10): 71-73.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>April 2018<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1433796\">Is It Ethically Appropriate to Refuse to Compensate Participants Who Are Believed to Have Intentionally Concealed Medical Conditions?<\/a><br \/>\n<\/strong>Taylor HA and Morales C. <em>American Journal of Bioethics<\/em> 2018; 18(4): 83-84.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431703\">Mutual Obligations in Research and Withholding Payment From Deceptive Participants.<\/a><br \/>\nFernandez Lynch H, Gelinas L, Largent EA. <em>American Journal of Bioethics<\/em> 2018; 18(4): 85-87.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431707\">Best to Exclude but Pay.<\/a><br \/>\nDanis M, Doernberg S, Memoli M, Millum J. <em>American Journal of Bioethics<\/em> 2018; 18(4): 87-88.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431720\">To Pay or Not to Pay? Withholding Payment From Research Participants.<\/a><br \/>\nRhodes R and Danziger M. <em>American Journal of Bioethics<\/em> 2018; 18(4): 88-90.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1433798\">Involving Pregnant Women in Research: What Should We Recommend When the Regulations Seem Ethically Problematic?<\/a><\/strong><br \/>\nTaylor HA and Morales C. <em>American Journal of Bioethics<\/em> 2018; 18(4): 91-92.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431704\">Conflicts Between Regulations and Ethical Principles: Resolving Ambiguity in Favor of the Ethically Preferable Outcome.<\/a><br \/>\nShah SK and Porter K. <em>American Journal of Bioethics<\/em> 2018; 18(4): 93-94.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431721\">When to Avoid Giving Advice on the Ethical Conduct of Research.<\/a><br \/>\nSharp RR and Allyse MA. <em>American Journal of Bioethics<\/em> 2018; 18(4): 94-95.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431706\">When Research Regulations and Ethics Conflict.<\/a><br \/>\nSullivan HK, Braverman DW, Wendler D. <em>American Journal of Bioethics<\/em> 2018; 18(4): 96-97.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>October 2017<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1366199\">Expanded Access for Nusinersen in Patients With Spinal Muscular Atropy: Negotiating Limited Data, Limited Alternative Treatments, and Limited Hospital Resources.<\/a><br \/>\n<\/strong>Wilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(10): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365197\">Hard Choices for Vulnerable Patients: Some Lessons Learned That May Apply.<\/a><br \/>\nKearns L and Caplan AL. <em>American Journal of Bioethics<\/em> 2017; 17(10): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365196\">Is There a \u2018Right to Try\u2019 Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.<\/a><br \/>\nJecker NS. <em>American Journal of Bioethics<\/em> 2017; 17(10): 70-71.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365198\">Fairness and Transparency in an Expanded Access Program: Allocation of the Only Treatment for SMA1.<\/a><br \/>\nBurgart AM, Collier J, Cho MK. <em>American Journal of Bioethics<\/em> 2017; 17(10): 71-73.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1366200\">A Trial to Test a Novel Approach to Diabetes Prevention.<\/a><\/strong><br \/>\nTaylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(10): 74-75.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365201\">Is It Ethically Acceptable to Screen Patients for Obstructive Sleep Apnea and Not Offer Them Positive Air Pressure Therapy in a Clinical Trial?<\/a><br \/>\nMcCormick JB, Wu JT, Doussau A. <em>American Journal of Bioethics<\/em> 2017; 17(10): 76-77.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365199\">Can We Breathe Easy If PAP Therapy Is Withheld?<\/a><br \/>\nTaylor HA and Punjabi NM. <em>American Journal of Bioethics<\/em> 2017; 17(10): 78-79.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365200\">Risks of Clinical Research Must Be Reasonable and Necessary.<\/a><br \/>\nGibbes Miller D and Kim SYH. <em>American Journal of Bioethics<\/em> 2017; 17(10): 79-81.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>April 2017<\/strong><\/p>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284935\">Genotype-Driven Recruitment in Population-Based Biomedical Research.<\/a><\/strong><br \/>\nTaylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(4): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284924\">Genotype-Driven Recruitment Without Deception.<\/a><br \/>\nOssorio P and Mailick M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284920\">Harms of Deception in FMR1 Premutation Genotype-Driven Recruitment.<\/a><br \/>\nDoernberg S and Hull SC. <em>American Journal of Bioethics<\/em> 2017; 17(4): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284916\">Genotype-Driven Recruitment and the Disclosure of Individual Research Results.<\/a><br \/>\nBeskow LM. <em>American Journal of Bioethics<\/em> 2017; 17(4): 64-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284934\">Should Patients Be Required to Undergo Standard Chemotherapy Before Being Eligible for Novel Phase I Immunotherapy Clinical Trials?<\/a><\/strong><br \/>\nWilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(4): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284922\">A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.<\/a><br \/>\nDoussau A and Hanmer CB. <em>American Journal of Bioethics<\/em> 2017; 17(4): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284933\">Participation of Citizen Scientists in Clinical Research and Access to Research Ethics Consultation.<\/a><br \/>\nCollier E and Danis M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 70-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284936\">Forgoing Conventional Therapy in Phase I Oncology Research: Don&#8217;t Forget About the Children.<\/a><br \/>\nWetmore C. <em>American Journal of Bioethics<\/em> 2017; 17(4): 72-73<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Clinical Obligations to Research Participants&#8221;][vc_row_inner row_type=&#8221;row&#8221; type=&#8221;full_width&#8221; text_align=&#8221;left&#8221; css_animation=&#8221;&#8221;][vc_column_inner][vc_column_text]<strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654032\">A Cluster Randomized Trial to Screen for Abusive Head Trauma in the Pediatric Intensive Care Unit\u2014How to Manage Site-Specific Evidence of Racial\/Ethic Disparity.<\/a><br \/>\n<\/strong>Johnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 108-109.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654012\">Issues of Justice and Risk: Setting Stopping Criteria in Cluster-Randomized Trials.<\/a><br \/>\nTumilty E and Farroni JS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 110-111.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654015\">Clinical Trials Not Causing Harm With Potential for Realizing Benefit Should Continue.<\/a><br \/>\nJackson BM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 112-114.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654030\">Responding to Implicit Bias in Abusive Head Trauma Evaluations and Reporting in the PICU: Ethical Consideration During a Clinical Trial.<\/a><br \/>\nMcCormick JB and Hymel KP. <em>American Journal of Bioethics<\/em> 2019; 19(10): 114-115.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572831\">Should Research Participants Be Notified About Results of Currently Unknown by Potential Significance?<\/a><br \/>\n<\/strong>Johnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(4): 73-74.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572825\">The Need For National Guidance Around Informed Consent About GBCA Safety.<\/a><br \/>\nBrown SB. <em>American Journal of Bioethics<\/em> 2019; 19(4): 75-77.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572829\">Returning Individual Research Results Regarding Gadolinium Deposition in the Brain Is the Preferable Choice.<\/a><br \/>\nHuang CJ, Bandettini WP, Danis M. <em>American Journal of Bioethics<\/em> 2019; 19(4): 77-78.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572830\">Research Participants Should Have the Option to Be Notified of Results of Unknown but Potential Significance.<\/a><br \/>\nHutchinson N, Capron A, Doussau A. <em>American Journal of Bioethics<\/em> 2019; 19(4): 78-80.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1522167\">Ethical Considerations for Unblinding a Participant\u2019s Assignment to Interpret a Resolved Adverse Event.<\/a><\/strong><br \/>\nWilfond BS, Morales C, Johnson LM, Taylor HA. <em>American Journal of Bioethics<\/em> 2018; 18(10): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513588\">Considerations for Unblinding in Biopharmaceutical Industry Sponsored Trials.<\/a><br \/>\nShah JJ and Bond J. <em>American Journal of Bioethics<\/em> 2018; 18(10): 68-70.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513590\">Blinds and Research Risks.<\/a><br \/>\nSteel R and Danis M. <em>American Journal of Bioethics<\/em> 2018; 18(10): 70-71.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513589\">The Scientific and Social Implications of Unblinding a Study Subject.<\/a><br \/>\nQuittell LM. <em>American Journal of Bioethics<\/em> 2018; 18(10): 71-73.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1366199\">Expanded Access for Nusinersen in Patients With Spinal Muscular Atropy: Negotiating Limited Data, Limited Alternative Treatments, and Limited Hospital Resources.<\/a><br \/>\n<\/strong>Wilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(10): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365197\">Hard Choices for Vulnerable Patients: Some Lessons Learned That May Apply.<\/a><br \/>\nKearns L and Caplan AL. <em>American Journal of Bioethics<\/em> 2017; 17(10): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365196\">Is There a \u2018Right to Try\u2019 Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.<\/a><br \/>\nJecker NS. <em>American Journal of Bioethics<\/em> 2017; 17(10): 70-71.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365198\">Fairness and Transparency in an Expanded Access Program: Allocation of the Only Treatment for SMA1.<\/a><br \/>\nBurgart AM, Collier J, Cho MK. <em>American Journal of Bioethics<\/em> 2017; 17(10): 71-73.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1366200\">A Trial to Test a Novel Approach to Diabetes Prevention.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(10): 74-75.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365201\">Is It Ethically Acceptable to Screen Patients for Obstructive Sleep Apnea and Not Offer Them Positive Air Pressure Therapy in a Clinical Trial?<\/a><br \/>\nMcCormick JB, Wu JT, Doussau A. <em>American Journal of Bioethics<\/em> 2017; 17(10): 76-77.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365199\">Can We Breathe Easy If PAP Therapy Is Withheld?<\/a><br \/>\nTaylor HA and Punjabi NM. <em>American Journal of Bioethics<\/em> 2017; 17(10): 78-79.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365200\">Risks of Clinical Research Must Be Reasonable and Necessary.<\/a><br \/>\nGibbes Miller D and Kim SYH. <em>American Journal of Bioethics<\/em> 2017; 17(10): 79-81.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284935\">Genotype-Driven Recruitment in Population-Based Biomedical Research.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(4): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284924\">Genotype-Driven Recruitment Without Deception.<\/a><br \/>\nOssorio P and Mailick M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284920\">Harms of Deception in FMR1 Premutation Genotype-Driven Recruitment.<\/a><br \/>\nDoernberg S and Hull SC. <em>American Journal of Bioethics<\/em> 2017; 17(4): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284916\">Genotype-Driven Recruitment and the Disclosure of Individual Research Results.<\/a><br \/>\nBeskow LM. <em>American Journal of Bioethics<\/em> 2017; 17(4): 64-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214329\">When a Clinical Trial Is the Only Option.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2016; 16(10): 67-68.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214306\">\u201cRespect for Persons,\u201d Not \u201cRespect for Citizens\u201d.<\/a><br \/>\nFabi R. <em>American Journal of Bioethics<\/em> 2016; 16(10): 69-70.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214324\">The Potentially High Cost of a Free Clinical Trial.<\/a><br \/>\nHeitman E. <em>American Journal of Bioethics<\/em> 2016; 16(10): 70-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214315\">Contextualizing \u201cChoice\u201d for Undocumented Immigrants in U.S. Clinical Trials Research.<\/a><br \/>\nBurke, NJ. <em>American Journal of Bioethics<\/em> 2016; 16(10): 72-74.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1146541\">Obligations to Act on Patient Reported Outcomes in Electronic Health Records.<\/a><br \/>\n<\/strong><em>American Journal of Bioethics<\/em> 2016; 16(4): 62.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145300\">Informed Consent for PROs in EHR Research: Are Additional Requirements Necessary?<\/a><br \/>\nWhicher D and Evans E. <em>American Journal of Bioethics<\/em> 2016; 16(4): 63-65.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145299\">Patient Reported Outcomes at the Crossroads of Clinical Research and Informatics.<\/a><br \/>\nSwirsky ES and Boyd AD. <em>American Journal of Bioethics<\/em> 2016; 16(4): 65-66.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1146543\">PROs in the Balance: Ethical Implications of Collecting Patient Reported Outcome Measures in the Electronic Health Record.<\/a><br \/>\nCrites JS, Chuang C, Dimmock A, Hwang W, Johannes B, Paranjape A, Wu AW. <em>American Journal of Bioethics<\/em> 2016; 16(4): 67-68.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947806\">The Obligations to Report Statutory Sexual Abuse Disclosed in a Research Study.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2014; 14(10): 50.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947817\">The Moral and Legal Need to Disclose Despite a Certificate of Confidentiality.<\/a><br \/>\nPaquette ET and Ross LF. <em>American Journal of Bioethics<\/em> 2014; 14(10): 51-53.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947818\">Informed Consent and the Implications for Statutory Rape Reporting in Research With Adolescents.<\/a><br \/>\nHodgkinson S, Lewin A, Chang B, Beers L, Silber T. <em>American Journal of Bioethics<\/em> 2014; 14(10): 54-55.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947819\">Community, Context, and the Contrasting Roles of Clinicians and Researchers: Challenges Raised by Statutory Rape.<\/a><br \/>\nFinder SG and Korenman S. <em>American Journal of Bioethics<\/em> 2014; 14(10): 55-57.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889943\">The Ethics of Disclosing to Research Subjects the Availability of Off-Label Marketed Drugs.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2014; 14(4): 51.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889946\">Researchers Have an Ethical Obligation to Disclose the Availability of Off-Label Marketed Drugs.<\/a><br \/>\nSilber TJ. <em>American Journal of Bioethics<\/em> 2014; 14(4): 52.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889950\">The Relevance of Research Study Phase to Disclosure of Off-Label Drug Availability.<\/a><br \/>\nBaskaran A and Sade RM. <em>American Journal of Bioethics<\/em> 2014; 14(4): 53-54.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889954\">Which Alternatives Should Investigators Disclose to Research Subjects?<\/a><br \/>\nPhillips J and Wendler D. <em>American Journal of Bioethics<\/em> 2014; 14(4): 54-55.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889956\">Ethics of Continuing to Provide a Drug on an Open-Label Extension Study for an \u201cUnapproved Indication\u201d.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2014; 14(4): 56.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889957\">When Should Open-Label Extension Studies Be Stopped?<\/a><br \/>\nCrites JS. <em>American Journal of Bioethics<\/em> 2014; 14(4): 57-58.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889959\">The Role of Clinical Equipoise and Practical Considerations in Deciding Whether to Continue to Provide a Drug on an Open-Label Extension Study for an \u201cUnapproved Indication\u201d.<\/a><br \/>\nNash RR. <em>American Journal of Bioethics<\/em> 2014; 14(4): 59-60.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889958\">Open-Label Extension Studies: Are They Really Research?<\/a><br \/>\nCho MK. <em>American Journal of Bioethics<\/em> 2014; 14(4): 60-61.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Community \/ Cultural Concerns&#8221;][vc_column_text]<strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654032\">A Cluster Randomized Trial to Screen for Abusive Head Trauma in the Pediatric Intensive Care Unit\u2014How to Manage Site-Specific Evidence of Racial\/Ethic Disparity.<\/a><\/strong><br \/>\nJohnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 108-109.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654012\">Issues of Justice and Risk: Setting Stopping Criteria in Cluster-Randomized Trials.<\/a><br \/>\nTumilty E and Farroni JS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 110-111.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654015\">Clinical Trials Not Causing Harm With Potential for Realizing Benefit Should Continue.<\/a><br \/>\nJackson BM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 112-114.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654030\">Responding to Implicit Bias in Abusive Head Trauma Evaluations and Reporting in the PICU: Ethical Consideration During a Clinical Trial.<\/a><br \/>\nMcCormick JB and Hymel KP. <em>American Journal of Bioethics<\/em> 2019; 19(10): 114-115.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214329\">When a Clinical Trial Is the Only Option.<\/a><\/strong><br \/>\nTaylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2016; 16(10): 67-68.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214306\">\u201cRespect for Persons,\u201d Not \u201cRespect for Citizens\u201d.<\/a><br \/>\nFabi R. <em>American Journal of Bioethics<\/em> 2016; 16(10): 69-70.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214324\">The Potentially High Cost of a Free Clinical Trial.<\/a><br \/>\nHeitman E. <em>American Journal of Bioethics<\/em> 2016; 16(10): 70-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214315\">Contextualizing \u201cChoice\u201d for Undocumented Immigrants in U.S. Clinical Trials Research.<\/a><br \/>\nBurke, NJ. <em>American Journal of Bioethics<\/em> 2016; 16(10): 72-74.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214330\">Studying the Role of Financial Incentives to Promote Hepatitis B Vaccination in a Community Clinic.<\/a><\/strong><br \/>\nWilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2016; 16(10): 75-76.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214327\">Treatment Incentives and the Nature of the Doctor-Patient Relationship.<\/a><br \/>\nGiunta H. <em>American Journal of Bioethics<\/em> 2016; 16(10): 77-78.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214322\">The Ethics of Studying Financial Incentives in Public Health Implementation: Study Design Challenges.<\/a><br \/>\nDoussau A and Grady C. <em>American Journal of Bioethics<\/em> 2016; 16(10): 78-80.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214321\">You Can Lead a Horse to Water, But Can You Pay to Make Him Drink? An Ethical Analysis of Research on Using Incentives to Promote Patient Health.<\/a><br \/>\nPerumalswami P, Branch A, Rhodes R. <em>American Journal of Bioethics<\/em> 2016; 16(10): 80-82.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1146542\">Selecting Children for an Autism Spectrum Disorder Study: Justice and Geography.<\/a><\/strong><br \/>\n<em>American Journal of Bioethics<\/em> 2016; 16(4): 69-70.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145297\">Fair Participant Selection: A Negative Obligation Not to Exclude.<\/a><br \/>\nChen SC. <em>American Journal of Bioethics<\/em> 2016; 16(4): 71-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145298\">Unequal Individual Risk and Potential Benefit Balanced by Benefits to the Population at Large in Autism Clinical Trials?<\/a><br \/>\nStein MA and King BH. <em>American Journal of Bioethics<\/em> 2016; 16(4): 72-74.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145303\">Justice in Selecting Participants for a Study in Phelan-McDermid Syndrome.<\/a><br \/>\nRhodes R and Kolevzon A. <em>American Journal of Bioethics<\/em> 2016; 16(4): 74-76.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011009\">Protecting Research Subject Welfare in Preventive Trials for Autosomal Dominant Alzheimer&#8217;s Disease.<\/a><\/strong><br \/>\nTaylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 83-84.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011010\">When There Are Only Two Who Can Tango: Ethical Concerns at the Juncture of Highly Novel Interventions and Precisely Targeted Research Populations.<\/a><br \/>\nYarborough M. <em>American Journal of Bioethics<\/em> 2015; 15(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011012\">Conceptualization and Assessment of Vulnerability in a Complex International Alzheimer\u2019s Research Study.<\/a><br \/>\nKorenman S, Finder SG, Ringman JM. <em>American Journal of Bioethics<\/em> 2015; 15(4): 87-89.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011013\">Barriers and Facilitators to the Consent Process in a Study of Complex Genetic Factors.<\/a><br \/>\nSimpson AR. <em>American Journal of Bioethics<\/em> 2015; 15(4): 89-90.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Drugs &amp; Devices&#8221;][vc_row_inner row_type=&#8221;row&#8221; type=&#8221;full_width&#8221; text_align=&#8221;left&#8221; css_animation=&#8221;&#8221;][vc_column_inner][vc_column_text]<strong>Ethical Drug Development for Rare Childhood Diseases: When There are Limited but Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?<br \/>\n<\/strong>Johnson LM, Duenas DM, Wilfond BS. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/p>\n<ul>\n<li>The Use of Pediatric Extrapolation to Avoid Unnecessary Pediatric Clinical Trials.<br \/>\nNelson R. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>Flexibility Required: Balancing the Interests of Children and Risk in Drug Development for Rare Pediatric Conditions.<br \/>\nPorter KM, Stevens A, Wilfond BS. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.<br \/>\nMastler J and Young J. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<\/ul>\n<p><strong>Greater than Minimal Risk, No Direct Benefit \u2013 Bridging Drug Trials and Novel Therapy in Pediatric Populations.<br \/>\n<\/strong>Wilfond BS, Duenas DM, Johnson LM. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/p>\n<ul>\n<li>Balancing Risk and Reward: Research with Novel Therapies for Children with Life-limiting Illness.<br \/>\nUnguru Y. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>Bringing Known Drugs to Pediatric Research \u2013 Safety, Efficacy, and the Ambiguous Minor Increase in Minimal Risk.<br \/>\nSharma A and Johnson LM. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>Balancing Scientific Progress with Pediatric Protections: No Direct Benefit Now, but Potential Novel Therapy in the Future.<br \/>\nLee SW and Ginsberg JC. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1366199\">Expanded Access for Nusinersen in Patients With Spinal Muscular Atropy: Negotiating Limited Data, Limited Alternative Treatments, and Limited Hospital Resources.<\/a><br \/>\n<\/strong>Wilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(10): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365197\">Hard Choices for Vulnerable Patients: Some Lessons Learned That May Apply.<\/a><br \/>\nKearns L and Caplan AL. <em>American Journal of Bioethics<\/em> 2017; 17(10): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365196\">Is There a \u2018Right to Try\u2019 Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.<\/a><br \/>\nJecker NS. <em>American Journal of Bioethics<\/em> 2017; 17(10): 70-71.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365198\">Fairness and Transparency in an Expanded Access Program: Allocation of the Only Treatment for SMA1.<\/a><br \/>\nBurgart AM, Collier J, Cho MK. <em>American Journal of Bioethics<\/em> 2017; 17(10): 71-73.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284934\">Should Patients Be Required to Undergo Standard Chemotherapy Before Being Eligible for Novel Phase I Immunotherapy Clinical Trials?<\/a><br \/>\n<\/strong>Wilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(4): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284922\">A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.<\/a><br \/>\nDoussau A and Hanmer CB. <em>American Journal of Bioethics<\/em> 2017; 17(4): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284933\">Participation of Citizen Scientists in Clinical Research and Access to Research Ethics Consultation.<\/a><br \/>\nCollier E and Danis M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 70-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284936\">Forgoing Conventional Therapy in Phase I Oncology Research: Don&#8217;t Forget About the Children.<\/a><br \/>\nWetmore C. <em>American Journal of Bioethics<\/em> 2017; 17(4): 72-73.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011009\">Protecting Research Subject Welfare in Preventive Trials for Autosomal Dominant Alzheimer&#8217;s Disease.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 83-84.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011010\">When There Are Only Two Who Can Tango: Ethical Concerns at the Juncture of Highly Novel Interventions and Precisely Targeted Research Populations.<\/a><br \/>\nYarborough M. <em>American Journal of Bioethics<\/em> 2015; 15(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011012\">Conceptualization and Assessment of Vulnerability in a Complex International Alzheimer\u2019s Research Study.<\/a><br \/>\nKorenman S, Finder SG, Ringman JM. <em>American Journal of Bioethics<\/em> 2015; 15(4): 87-89.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011013\">Barriers and Facilitators to the Consent Process in a Study of Complex Genetic Factors.<\/a><br \/>\nSimpson AR. <em>American Journal of Bioethics<\/em> 2015; 15(4): 89-90.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889943\">The Ethics of Disclosing to Research Subjects the Availability of Off-Label Marketed Drugs.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2014; 14(4): 51.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889946\">Researchers Have an Ethical Obligation to Disclose the Availability of Off-Label Marketed Drugs.<\/a><br \/>\nSilber TJ. <em>American Journal of Bioethics<\/em> 2014; 14(4): 52.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889950\">The Relevance of Research Study Phase to Disclosure of Off-Label Drug Availability.<\/a><br \/>\nBaskaran A and Sade RM. <em>American Journal of Bioethics<\/em> 2014; 14(4): 53-54.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889954\">Which Alternatives Should Investigators Disclose to Research Subjects?<\/a><br \/>\nPhillips J and Wendler D. <em>American Journal of Bioethics<\/em> 2014; 14(4): 54-55.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889956\">Ethics of Continuing to Provide a Drug on an Open-Label Extension Study for an \u201cUnapproved Indication\u201d.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2014; 14(4): 56.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889957\">When Should Open-Label Extension Studies Be Stopped?<\/a><br \/>\nCrites JS. <em>American Journal of Bioethics<\/em> 2014; 14(4): 57-58.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889959\">The Role of Clinical Equipoise and Practical Considerations in Deciding Whether to Continue to Provide a Drug on an Open-Label Extension Study for an \u201cUnapproved Indication\u201d.<\/a><br \/>\nNash RR. <em>American Journal of Bioethics<\/em> 2014; 14(4): 59-60.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889958\">Open-Label Extension Studies: Are They Really Research?<\/a><br \/>\nCho MK. <em>American Journal of Bioethics<\/em> 2014; 14(4): 60-61.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Genetics&#8221;][vc_row_inner row_type=&#8221;row&#8221; type=&#8221;full_width&#8221; text_align=&#8221;left&#8221; css_animation=&#8221;&#8221;][vc_column_inner][vc_column_text]<strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572832\">The Limitation of &#8220;Boilerplate&#8221; Language in Informed Consent: Single IRB Review of Multisite Genetic Research in Military Personnel.<\/a><br \/>\n<\/strong>Wilfond BS, Zambrowski J, Johnson LM. <em>American Journal of Bioethics<\/em> 2019; 19(4): 81-82.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572827\">The Bane of &#8220;Boilerplate&#8221; Language in Research Consent Forms: Ensuring Consent Forms Promote Autonomous Authorization.<\/a><br \/>\nBotkin JR. <em>American Journal of Bioethics<\/em> 2019; 19(4): 83-84.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572828\">Single IRBs Are Responsible to Ensure Consent Language Effectively Conveys the Local Context.<\/a><br \/>\nHull SC and Schiffenbauer AI. <em>American Journal of Bioethics<\/em> 2019; 19(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572826\">Solving the Single IRB\/Boilerplate Bind: Establishing Institutional Guidelines.<\/a><br \/>\nAbraham ME, Hohmann E, Morash M. <em>American Journal of Bioethics<\/em> 2019; 19(4): 87-88.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284935\">Genotype-Driven Recruitment in Population-Based Biomedical Research.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(4): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284924\">Genotype-Driven Recruitment Without Deception.<\/a><br \/>\nOssorio P and Mailick M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284920\">Harms of Deception in FMR1 Premutation Genotype-Driven Recruitment.<\/a><br \/>\nDoernberg S and Hull SC. <em>American Journal of Bioethics<\/em> 2017; 17(4): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284916\">Genotype-Driven Recruitment and the Disclosure of Individual Research Results.<\/a><br \/>\nBeskow LM. <em>American Journal of Bioethics<\/em> 2017; 17(4): 64-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011009\">Protecting Research Subject Welfare in Preventive Trials for Autosomal Dominant Alzheimer&#8217;s Disease.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 83-84.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011010\">When There Are Only Two Who Can Tango: Ethical Concerns at the Juncture of Highly Novel Interventions and Precisely Targeted Research Populations.<\/a><br \/>\nYarborough M. <em>American Journal of Bioethics<\/em> 2015; 15(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011012\">Conceptualization and Assessment of Vulnerability in a Complex International Alzheimer\u2019s Research Study.<\/a><br \/>\nKorenman S, Finder SG, Ringman JM. <em>American Journal of Bioethics<\/em> 2015; 15(4): 87-89.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011013\">Barriers and Facilitators to the Consent Process in a Study of Complex Genetic Factors.<\/a><br \/>\nSimpson AR. <em>American Journal of Bioethics<\/em> 2015; 15(4): 89-90.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828523\">The Ethics of Contacting Family Members of a Subject in a Genetic Research Study to Return Results for an Autosomal Dominant Syndrome.<\/a><br \/>\n<\/strong>Taylor HA and Wilfond BS. <em>American Journal of Bioethics <\/em>2013; 13(10): 61.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828528\">What Does the Duty to Warn Require?<\/a><br \/>\nShah SK, Hull SC, Spinner MA, Berkman BE, Sanchez LA, Abdul-Karim R, Hsu AP, Claypool R, Holland SM. <em>American Journal of Bioethics<\/em> 2013; 13(10): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828531\">Should Researchers Disclose Results to Descendants?<\/a><br \/>\nRothstein MA. <em>American Journal of Bioethics <\/em>2013; 13(10): 64-65.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828533\">Relationships Matter: Ethical Considerations for Returning Results to Family Members of Deceased Subjects.<\/a><br \/>\nMilner LC, Liu EY, Garrison NA. <em>American Journal of Bioethics <\/em>2013; 13(10): 66-67.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Miscellaneous&#8221;][vc_row_inner row_type=&#8221;row&#8221; type=&#8221;full_width&#8221; text_align=&#8221;left&#8221; css_animation=&#8221;&#8221;][vc_column_inner][vc_column_text]<strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1433796\">Is It Ethically Appropriate to Refuse to Compensate Participants Who Are Believed to Have Intentionally Concealed Medical Conditions?<\/a><br \/>\n<\/strong>Taylor HA and Morales C. <em>American Journal of Bioethics<\/em> 2018; 18(4): 83-84.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431703\">Mutual Obligations in Research and Withholding Payment From Deceptive Participants.<\/a><br \/>\nFernandez Lynch H, Gelinas L, Largent EA. <em>American Journal of Bioethics<\/em> 2018; 18(4): 85-87.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431707\">Best to Exclude but Pay.<\/a><br \/>\nDanis M, Doernberg S, Memoli M, Millum J. <em>American Journal of Bioethics<\/em> 2018; 18(4): 87-88.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431720\">To Pay or Not to Pay? Withholding Payment From Research Participants.<\/a><br \/>\nRhodes R and Danziger M. <em>American Journal of Bioethics<\/em> 2018; 18(4): 88-90.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947820\">Ethical Implications of Social Media in Health Care Research.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2014; 14(10): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.948302\">Using Social Media in Research: New Ethics for a New Meme?<\/a><br \/>\nSwirsky ES, Hoop JG, Labott S. <em>American Journal of Bioethics<\/em> 2014; 14(10): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947823\">Connectivity and Consent: Does Posting Imply Participation?<\/a><br \/>\nFarnan JM. <em>American Journal of Bioethics<\/em> 2014; 14(10): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947825\">Conducting Research on Social Media\u2014Is Facebook Like the Public Square?<\/a><br \/>\nParsi K and Elster N. <em>American Journal of Bioethics<\/em> 2014; 14(10): 63-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828534\">Managing Disclosure of Research Misconduct by a Graduate Student to a University Mental Health Professional During a Clinical Counseling Session.<\/a><br \/>\n<\/strong>Taylor HA and Wilfond BS. <em>American Journal of Bioethics<\/em> 2013; 13(10): 68.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828537\">A Systems-Level Approach to Resolve Tension between Research Misconduct and Confidentiality.<\/a><br \/>\nLimehouse W. <em>American Journal of Bioethics<\/em> 2013; 13(10): 69-70.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828538\">Let Therapists Be Therapists, Not Police.<\/a><br \/>\nAppelbaum PS. <em>American Journal of Bioethics<\/em> 2013; 13(10): 71-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828539\">Why Misconduct Trumps Patient\u2013Therapist Confidentiality and Ways to Avoid the Disclosure Dilemma.<\/a><br \/>\nSteneck NH. <em>American Journal of Bioethics<\/em> 2013; 13(10): 73-74.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Pediatrics&#8221;][vc_row_inner row_type=&#8221;row&#8221; type=&#8221;full_width&#8221; text_align=&#8221;left&#8221; css_animation=&#8221;&#8221;][vc_column_inner][vc_column_text]<strong>Ethical Drug Development for Rare Childhood Diseases: When There are Limited but Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?<br \/>\n<\/strong>Johnson LM, Duenas DM, Wilfond BS. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/p>\n<ul>\n<li>The Use of Pediatric Extrapolation to Avoid Unnecessary Pediatric Clinical Trials.<br \/>\nNelson R. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>Flexibility Required: Balancing the Interests of Children and Risk in Drug Development for Rare Pediatric Conditions.<br \/>\nPorter KM, Stevens A, Wilfond BS. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.<br \/>\nMastler J and Young J. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<\/ul>\n<p><strong>Greater than Minimal Risk, No Direct Benefit \u2013 Bridging Drug Trials and Novel Therapy in Pediatric Populations.<br \/>\n<\/strong>Wilfond BS, Duenas DM, Johnson LM. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/p>\n<ul>\n<li>Balancing Risk and Reward: Research with Novel Therapies for Children with Life-limiting Illness.<br \/>\nUnguru Y. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>Bringing Known Drugs to Pediatric Research \u2013 Safety, Efficacy, and the Ambiguous Minor Increase in Minimal Risk.<br \/>\nSharma A and Johnson LM. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>Balancing Scientific Progress with Pediatric Protections: No Direct Benefit Now, but Potential Novel Therapy in the Future.<br \/>\nLee SW and Ginsberg JC. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654032\">A Cluster Randomized Trial to Screen for Abusive Head Trauma in the Pediatric Intensive Care Unit\u2014How to Manage Site-Specific Evidence of Racial\/Ethic Disparity.<\/a><br \/>\n<\/strong>Johnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 108-109.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654012\">Issues of Justice and Risk: Setting Stopping Criteria in Cluster-Randomized Trials.<\/a><br \/>\nTumilty E and Farroni JS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 110-111.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654015\">Clinical Trials Not Causing Harm With Potential for Realizing Benefit Should Continue.<\/a><br \/>\nJackson BM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 112-114.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654030\">Responding to Implicit Bias in Abusive Head Trauma Evaluations and Reporting in the PICU: Ethical Consideration During a Clinical Trial.<\/a><br \/>\nMcCormick JB and Hymel KP. <em>American Journal of Bioethics<\/em> 2019; 19(10): 114-115.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1366199\">Expanded Access for Nusinersen in Patients With Spinal Muscular Atropy: Negotiating Limited Data, Limited Alternative Treatments, and Limited Hospital Resources.<\/a><br \/>\n<\/strong>Wilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(10): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365197\">Hard Choices for Vulnerable Patients: Some Lessons Learned That May Apply.<\/a><br \/>\nKearns L and Caplan AL. <em>American Journal of Bioethics<\/em> 2017; 17(10): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365196\">Is There a \u2018Right to Try\u2019 Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.<\/a><br \/>\nJecker NS. <em>American Journal of Bioethics<\/em> 2017; 17(10): 70-71.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365198\">Fairness and Transparency in an Expanded Access Program: Allocation of the Only Treatment for SMA1.<\/a><br \/>\nBurgart AM, Collier J, Cho MK. <em>American Journal of Bioethics<\/em> 2017; 17(10): 71-73.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1146542\">Selecting Children for an Autism Spectrum Disorder Study: Justice and Geography.<\/a><br \/>\n<\/strong><em>American Journal of Bioethics<\/em> 2016; 16(4): 69-70.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145297\">Fair Participant Selection: A Negative Obligation Not to Exclude.<\/a><br \/>\nChen SC. <em>American Journal of Bioethics<\/em> 2016; 16(4): 71-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145298\">Unequal Individual Risk and Potential Benefit Balanced by Benefits to the Population at Large in Autism Clinical Trials?<\/a><br \/>\nStein MA and King BH. <em>American Journal of Bioethics<\/em> 2016; 16(4): 72-74.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145303\">Justice in Selecting Participants for a Study in Phelan-McDermid Syndrome.<\/a><br \/>\nRhodes R and Kolevzon A. <em>American Journal of Bioethics<\/em> 2016; 16(4): 74-76.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075795\">Recontact and Recruitment of Young Adults Previously Enrolled in Neonatal Herpes Simplex Virus Research.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(10): 56-57.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075798\">Research Recruitment of Adult Survivors of Neonatal Infections: Is There a Role for Parental Consent?<\/a><br \/>\nMelvin AJ, Mohan KM, Wald A, Porter K, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(10): 58-59.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075799\">A Knotty Problem of Intertwined Rights.<\/a><br \/>\nMcKinney RE. <em>American Journal of Bioethics<\/em> 2015; 15(10): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075800\">Consent Is the Cornerstone of Ethically Valid Research: Ethical Issues in Recontacting Subjects Who Enrolled in Research as a Minor.<\/a><br \/>\nPaquette ET and Ross LF. <em>American Journal of Bioethics<\/em> 2015; 15(10): 61-63.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011003\">Navigating Parental Permission for Neonatal Research.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 76.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011005\">Informed Consent and Parental Permission for Research: Rules, Roles, and Relationships.<\/a><br \/>\nFiore RN and Cushman R. <em>American Journal of Bioethics<\/em> 2015; 15(4): 77-78.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011006\">Research Involving Premature Infants: Timing Is Everything.<\/a><br \/>\nEisenberg LR. <em>American Journal of Bioethics<\/em> 2015; 15(4): 79-80.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011007\">Precluding Consent by Clinicians Who Are Both the Attending and the Investigator: An Outdated Shibboleth?<\/a><br \/>\nShah A, Porter K, Juul S, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 80-82.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947806\">The Obligations to Report Statutory Sexual Abuse Disclosed in a Research Study.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2014; 14(10): 50.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947817\">The Moral and Legal Need to Disclose Despite a Certificate of Confidentiality.<\/a><br \/>\nPaquette ET and Ross LF. <em>American Journal of Bioethics<\/em> 2014; 14(10): 51-53.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947818\">Informed Consent and the Implications for Statutory Rape Reporting in Research With Adolescents.<\/a><br \/>\nHodgkinson S, Lewin A, Chang B, Beers L, Silber T. <em>American Journal of Bioethics<\/em> 2014; 14(10): 54-55.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947819\">Community, Context, and the Contrasting Roles of Clinicians and Researchers: Challenges Raised by Statutory Rape.<\/a><br \/>\nFinder SG and Korenman S. <em>American Journal of Bioethics<\/em> 2014; 14(10): 55-57.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Recruitment and Consent&#8221;][vc_row_inner row_type=&#8221;row&#8221; type=&#8221;full_width&#8221; text_align=&#8221;left&#8221; css_animation=&#8221;&#8221;][vc_column_inner][vc_column_text]<strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654024\">A Pragmatic Trial of Suicide Risk Assessment and Ambulance Transport Decision Making Among Emergency Medical Services Providers: Implications for Patient Consent.<\/a><br \/>\n<\/strong>Wilfond BS, Zambrowski J, Johnson LM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 97-98.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654017\">Improving Care for Suicidal Patients While Protecting Human Subjects: Addressing Ethical Challenges in Mental Health Research Involving Emergency Medical Services Providers.<\/a><br \/>\nDeCou CR, Shah SK, Porter KM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 99-101.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654013\">A Stepwise Approach to Ethically Assess Pragmatic Cluster Randomized Trials: Implications for Informed Consent for Suicide Prevention Implementation Research.<\/a><br \/>\nGoldstein CE and Weijer C. <em>American Journal of Bioethics<\/em> 2019; 19(10): 101-103.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654014\">Informed Consent in a Pragmatic Emergency Suicide Trial: Rejecting the Research\u2013Practice Distinction.<\/a><br \/>\nCanavera K and Parris K. <em>American Journal of Bioethics<\/em> 2019; 19(10): 103-105.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654020\">A Pragmatic Trial for Emergency Medical Service Providers\u2019 Prehospital Response to Suidality: Consent Is Not Essential, but Limited Patient Engagement May Be Meaningful.<\/a><br \/>\nDickert NW. <em>American Journal of Bioethics<\/em> 2019; 19(10): 105-107.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572832\">The Limitation of &#8220;Boilerplate&#8221; Language in Informed Consent: Single IRB Review of Multisite Genetic Research in Military Personnel.<\/a><br \/>\n<\/strong>Wilfond BS, Zambrowski J, Johnson LM. <em>American Journal of Bioethics<\/em> 2019; 19(4): 81-82.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572827\">The Bane of &#8220;Boilerplate&#8221; Language in Research Consent Forms: Ensuring Consent Forms Promote Autonomous Authorization.<\/a><br \/>\nBotkin JR. <em>American Journal of Bioethics<\/em> 2019; 19(4): 83-84.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572828\">Single IRBs Are Responsible to Ensure Consent Language Effectively Conveys the Local Context.<\/a><br \/>\nHull SC and Schiffenbauer AI. <em>American Journal of Bioethics<\/em> 2019; 19(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572826\">Solving the Single IRB\/Boilerplate Bind: Establishing Institutional Guidelines.<\/a><br \/>\nAbraham ME, Hohmann E, Morash M. <em>American Journal of Bioethics<\/em> 2019; 19(4): 87-88.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284935\">Genotype-Driven Recruitment in Population-Based Biomedical Research.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(4): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284924\">Genotype-Driven Recruitment Without Deception.<\/a><br \/>\nOssorio P and Mailick M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284920\">Harms of Deception in FMR1 Premutation Genotype-Driven Recruitment.<\/a><br \/>\nDoernberg S and Hull SC. <em>American Journal of Bioethics<\/em> 2017; 17(4): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284916\">Genotype-Driven Recruitment and the Disclosure of Individual Research Results.<\/a><br \/>\nBeskow LM. <em>American Journal of Bioethics<\/em> 2017; 17(4): 64-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284934\">Should Patients Be Required to Undergo Standard Chemotherapy Before Being Eligible for Novel Phase I Immunotherapy Clinical Trials?<\/a><br \/>\n<\/strong>Wilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(4): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284922\">A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.<\/a><br \/>\nDoussau A and Hanmer CB. <em>American Journal of Bioethics<\/em> 2017; 17(4): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284933\">Participation of Citizen Scientists in Clinical Research and Access to Research Ethics Consultation.<\/a><br \/>\nCollier E and Danis M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 70-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284936\">Forgoing Conventional Therapy in Phase I Oncology Research: Don&#8217;t Forget About the Children.<\/a><br \/>\nWetmore C. <em>American Journal of Bioethics<\/em> 2017; 17(4): 72-73.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214329\">When a Clinical Trial Is the Only Option.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2016; 16(10): 67-68.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214306\">\u201cRespect for Persons,\u201d Not \u201cRespect for Citizens\u201d.<\/a><br \/>\nFabi R. <em>American Journal of Bioethics<\/em> 2016; 16(10): 69-70.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214324\">The Potentially High Cost of a Free Clinical Trial.<\/a><br \/>\nHeitman E. <em>American Journal of Bioethics<\/em> 2016; 16(10): 70-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214315\">Contextualizing \u201cChoice\u201d for Undocumented Immigrants in U.S. Clinical Trials Research.<\/a><br \/>\nBurke, NJ. <em>American Journal of Bioethics<\/em> 2016; 16(10): 72-74.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214330\">Studying the Role of Financial Incentives to Promote Hepatitis B Vaccination in a Community Clinic.<\/a><br \/>\n<\/strong>Wilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2016; 16(10): 75-76.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214327\">Treatment Incentives and the Nature of the Doctor-Patient Relationship.<\/a><br \/>\nGiunta H. <em>American Journal of Bioethics<\/em> 2016; 16(10): 77-78.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214322\">The Ethics of Studying Financial Incentives in Public Health Implementation: Study Design Challenges.<\/a><br \/>\nDoussau A and Grady C. <em>American Journal of Bioethics<\/em> 2016; 16(10): 78-80.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1214321\">You Can Lead a Horse to Water, But Can You Pay to Make Him Drink? An Ethical Analysis of Research on Using Incentives to Promote Patient Health.<\/a><br \/>\nPerumalswami P, Branch A, Rhodes R. <em>American Journal of Bioethics<\/em> 2016; 16(10): 80-82.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1146542\">Selecting Children for an Autism Spectrum Disorder Study: Justice and Geography.<\/a><br \/>\n<\/strong><em>American Journal of Bioethics<\/em> 2016; 16(4): 69-70.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145297\">Fair Participant Selection: A Negative Obligation Not to Exclude.<\/a><br \/>\nChen SC. <em>American Journal of Bioethics<\/em> 2016; 16(4): 71-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145298\">Unequal Individual Risk and Potential Benefit Balanced by Benefits to the Population at Large in Autism Clinical Trials?<\/a><br \/>\nStein MA and King BH. <em>American Journal of Bioethics<\/em> 2016; 16(4): 72-74.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145303\">Justice in Selecting Participants for a Study in Phelan-McDermid Syndrome.<\/a><br \/>\nRhodes R and Kolevzon A. <em>American Journal of Bioethics<\/em> 2016; 16(4): 74-76.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075795\">Recontact and Recruitment of Young Adults Previously Enrolled in Neonatal Herpes Simplex Virus Research.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(10): 56-57.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075798\">Research Recruitment of Adult Survivors of Neonatal Infections: Is There a Role for Parental Consent?<\/a><br \/>\nMelvin AJ, Mohan KM, Wald A, Porter K, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(10): 58-59.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075799\">A Knotty Problem of Intertwined Rights.<\/a><br \/>\nMcKinney RE. <em>American Journal of Bioethics<\/em> 2015; 15(10): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075800\">Consent Is the Cornerstone of Ethically Valid Research: Ethical Issues in Recontacting Subjects Who Enrolled in Research as a Minor.<\/a><br \/>\nPaquette ET and Ross LF. <em>American Journal of Bioethics<\/em> 2015; 15(10): 61-63.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075801\">Is It Ethical to Enroll Cognitively Impaired Adults in Research That Is More Than Minimal Risk With No Prospect of Benefit?<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(10): 64-65.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075803\">Inconsistent Approaches to Research Involving Cognitively Impaired Adults: Why the Broad View of Substituted Judgment Is Our Best Guide.<\/a><br \/>\nYarborough M. <em>American Journal of Bioethics<\/em> 2015; 15(10): 66-67.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075805\">Ethical and Regulatory Considerations Regarding Enrollment of Incompetent Adults in More Than Minimal Risk Research as Compared With Children.<\/a><br \/>\nDerse AR and Spellecy R. <em>American Journal of Bioethics<\/em> 2015; 15(10): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075806\">Acceptable Approaches to Enrolling Adults Who Cannot Consent in More Than Minimal Risk Research.<\/a><br \/>\nDanis M, Wendler D, Kim S. <em>American Journal of Bioethics<\/em> 2015; 15(10): 70-71.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011003\">Navigating Parental Permission for Neonatal Research.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 76.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011005\">Informed Consent and Parental Permission for Research: Rules, Roles, and Relationships.<\/a><br \/>\nFiore RN and Cushman R. <em>American Journal of Bioethics<\/em> 2015; 15(4): 77-78.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011006\">Research Involving Premature Infants: Timing Is Everything.<\/a><br \/>\nEisenberg LR. <em>American Journal of Bioethics<\/em> 2015; 15(4): 79-80.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011007\">Precluding Consent by Clinicians Who Are Both the Attending and the Investigator: An Outdated Shibboleth?<\/a><br \/>\nShah A, Porter K, Juul S, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 80-82.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011009\">Protecting Research Subject Welfare in Preventive Trials for Autosomal Dominant Alzheimer&#8217;s Disease.<\/a><\/strong><br \/>\nTaylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 83-84.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011010\">When There Are Only Two Who Can Tango: Ethical Concerns at the Juncture of Highly Novel Interventions and Precisely Targeted Research Populations.<\/a><br \/>\nYarborough M. <em>American Journal of Bioethics<\/em> 2015; 15(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011012\">Conceptualization and Assessment of Vulnerability in a Complex International Alzheimer\u2019s Research Study.<\/a><br \/>\nKorenman S, Finder SG, Ringman JM. <em>American Journal of Bioethics<\/em> 2015; 15(4): 87-89.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011013\">Barriers and Facilitators to the Consent Process in a Study of Complex Genetic Factors.<\/a><br \/>\nSimpson AR. <em>American Journal of Bioethics<\/em> 2015; 15(4): 89-90.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889943\">The Ethics of Disclosing to Research Subjects the Availability of Off-Label Marketed Drugs.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2014; 14(4): 51.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889946\">Researchers Have an Ethical Obligation to Disclose the Availability of Off-Label Marketed Drugs.<\/a><br \/>\nSilber TJ. <em>American Journal of Bioethics<\/em> 2014; 14(4): 52.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889950\">The Relevance of Research Study Phase to Disclosure of Off-Label Drug Availability.<\/a><br \/>\nBaskaran A and Sade RM. <em>American Journal of Bioethics<\/em> 2014; 14(4): 53-54.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.889954\">Which Alternatives Should Investigators Disclose to Research Subjects?<\/a><br \/>\nPhillips J and Wendler D. <em>American Journal of Bioethics<\/em> 2014; 14(4): 54-55.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Results Disclosure&#8221;][vc_row_inner row_type=&#8221;row&#8221; type=&#8221;full_width&#8221; text_align=&#8221;left&#8221; css_animation=&#8221;&#8221;][vc_column_inner][vc_column_text]<strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654032\">A Cluster Randomized Trial to Screen for Abusive Head Trauma in the Pediatric Intensive Care Unit\u2014How to Manage Site-Specific Evidence of Racial\/Ethic Disparity.<\/a><br \/>\n<\/strong>Johnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 108-109.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654012\">Issues of Justice and Risk: Setting Stopping Criteria in Cluster-Randomized Trials.<\/a><br \/>\nTumilty E and Farroni JS. <em>American Journal of Bioethics<\/em> 2019; 19(10): 110-111.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654015\">Clinical Trials Not Causing Harm With Potential for Realizing Benefit Should Continue.<\/a><br \/>\nJackson BM. <em>American Journal of Bioethics<\/em> 2019; 19(10): 112-114.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1654030\">Responding to Implicit Bias in Abusive Head Trauma Evaluations and Reporting in the PICU: Ethical Consideration During a Clinical Trial.<\/a><br \/>\nMcCormick JB and Hymel KP. <em>American Journal of Bioethics<\/em> 2019; 19(10): 114-115.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572831\">Should Research Participants Be Notified About Results of Currently Unknown by Potential Significance?<\/a><br \/>\n<\/strong>Johnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(4): 73-74.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572825\">The Need For National Guidance Around Informed Consent About GBCA Safety.<\/a><br \/>\nBrown SB. <em>American Journal of Bioethics<\/em> 2019; 19(4): 75-77.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572829\">Returning Individual Research Results Regarding Gadolinium Deposition in the Brain Is the Preferable Choice.<\/a><br \/>\nHuang CJ, Bandettini WP, Danis M. <em>American Journal of Bioethics<\/em> 2019; 19(4): 77-78.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572830\">Research Participants Should Have the Option to Be Notified of Results of Unknown but Potential Significance.<\/a><br \/>\nHutchinson N, Capron A, Doussau A. <em>American Journal of Bioethics<\/em> 2019; 19(4): 78-80.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284935\">Genotype-Driven Recruitment in Population-Based Biomedical Research.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(4): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284924\">Genotype-Driven Recruitment Without Deception.<\/a><br \/>\nOssorio P and Mailick M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284920\">Harms of Deception in FMR1 Premutation Genotype-Driven Recruitment.<\/a><br \/>\nDoernberg S and Hull SC. <em>American Journal of Bioethics<\/em> 2017; 17(4): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284916\">Genotype-Driven Recruitment and the Disclosure of Individual Research Results.<\/a><br \/>\nBeskow LM. <em>American Journal of Bioethics<\/em> 2017; 17(4): 64-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075795\">Recontact and Recruitment of Young Adults Previously Enrolled in Neonatal Herpes Simplex Virus Research.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(10): 56-57.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075798\">Research Recruitment of Adult Survivors of Neonatal Infections: Is There a Role for Parental Consent?<\/a><br \/>\nMelvin AJ, Mohan KM, Wald A, Porter K, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(10): 58-59.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075799\">A Knotty Problem of Intertwined Rights.<\/a><br \/>\nMcKinney RE. <em>American Journal of Bioethics<\/em> 2015; 15(10): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075800\">Consent Is the Cornerstone of Ethically Valid Research: Ethical Issues in Recontacting Subjects Who Enrolled in Research as a Minor.<\/a><br \/>\nPaquette ET and Ross LF. <em>American Journal of Bioethics<\/em> 2015; 15(10): 61-63.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011009\">Protecting Research Subject Welfare in Preventive Trials for Autosomal Dominant Alzheimer&#8217;s Disease.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 83-84.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011010\">When There Are Only Two Who Can Tango: Ethical Concerns at the Juncture of Highly Novel Interventions and Precisely Targeted Research Populations.<\/a><br \/>\nYarborough M. <em>American Journal of Bioethics<\/em> 2015; 15(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011012\">Conceptualization and Assessment of Vulnerability in a Complex International Alzheimer\u2019s Research Study.<\/a><br \/>\nKorenman S, Finder SG, Ringman JM. <em>American Journal of Bioethics<\/em> 2015; 15(4): 87-89.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011013\">Barriers and Facilitators to the Consent Process in a Study of Complex Genetic Factors.<\/a><br \/>\nSimpson AR. <em>American Journal of Bioethics<\/em> 2015; 15(4): 89-90.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828523\">The Ethics of Contacting Family Members of a Subject in a Genetic Research Study to Return Results for an Autosomal Dominant Syndrome.<\/a><br \/>\n<\/strong>Taylor HA and Wilfond BS. <em>American Journal of Bioethics <\/em>2013; 13(10): 61.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828528\">What Does the Duty to Warn Require?<\/a><br \/>\nShah SK, Hull SC, Spinner MA, Berkman BE, Sanchez LA, Abdul-Karim R, Hsu AP, Claypool R, Holland SM. <em>American Journal of Bioethics<\/em> 2013; 13(10): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828531\">Should Researchers Disclose Results to Descendants?<\/a><br \/>\nRothstein MA. <em>American Journal of Bioethics <\/em>2013; 13(10): 64-65.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2013.828533\">Relationships Matter: Ethical Considerations for Returning Results to Family Members of Deceased Subjects.<\/a><br \/>\nMilner LC, Liu EY, Garrison NA. <em>American Journal of Bioethics <\/em>2013; 13(10): 66-67.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Risks &amp; Benefits&#8221; background_color=&#8221;#ffffff&#8221; title_color=&#8221;#ffffff&#8221;][vc_column_text]<strong>Ethical Drug Development for Rare Childhood Diseases: When There are Limited but Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?<br \/>\n<\/strong>Johnson LM, Duenas DM, Wilfond BS. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/p>\n<ul>\n<li>The Use of Pediatric Extrapolation to Avoid Unnecessary Pediatric Clinical Trials.<br \/>\nNelson R. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>Flexibility Required: Balancing the Interests of Children and Risk in Drug Development for Rare Pediatric Conditions.<br \/>\nPorter KM, Stevens A, Wilfond BS. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>When Higher Risk Does Not Equal Greater Harm: Doing the Most Good in a Limited Pediatric Study Population.<br \/>\nMastler J and Young J. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<\/ul>\n<p><strong>Greater than Minimal Risk, No Direct Benefit \u2013 Bridging Drug Trials and Novel Therapy in Pediatric Populations.<br \/>\n<\/strong>Wilfond BS, Duenas DM, Johnson LM. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/p>\n<ul>\n<li>Balancing Risk and Reward: Research with Novel Therapies for Children with Life-limiting Illness.<br \/>\nUnguru Y. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>Bringing Known Drugs to Pediatric Research \u2013 Safety, Efficacy, and the Ambiguous Minor Increase in Minimal Risk.<br \/>\nSharma A and Johnson LM. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<li>Balancing Scientific Progress with Pediatric Protections: No Direct Benefit Now, but Potential Novel Therapy in the Future.<br \/>\nLee SW and Ginsberg JC. <em>American Journal of Bioethics<\/em> 2020; 20(4): XX-XX.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572831\">Should Research Participants Be Notified About Results of Currently Unknown by Potential Significance?<\/a><br \/>\n<\/strong>Johnson LM, Zabrowski J, Wilfond BS. <em>American Journal of Bioethics<\/em> 2019; 19(4): 73-74.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572825\">The Need For National Guidance Around Informed Consent About GBCA Safety.<\/a><br \/>\nBrown SB. <em>American Journal of Bioethics<\/em> 2019; 19(4): 75-77.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572829\">Returning Individual Research Results Regarding Gadolinium Deposition in the Brain Is the Preferable Choice.<\/a><br \/>\nHuang CJ, Bandettini WP, Danis M. <em>American Journal of Bioethics<\/em> 2019; 19(4): 77-78.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2019.1572830\">Research Participants Should Have the Option to Be Notified of Results of Unknown but Potential Significance.<\/a><br \/>\nHutchinson N, Capron A, Doussau A. <em>American Journal of Bioethics<\/em> 2019; 19(4): 78-80.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1522166\">A Randomized Trial of Rapamycin to Increase Longevity and Healthspan in Companion Animals: Navigating the Boundary Between Protections for Animal Research and Human Subjects Research.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Johnson LM, Wilfond BS. <em>American Journal of Bioethics<\/em> 2018; 18(10): 58-59.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513586\">Rapamycin: Risking Harm for Canine Longevity.<\/a><br \/>\nAbbate C. <em>American Journal of Bioethics<\/em> 2018; 18(10): 60-61.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513587\">Companion Animal Studies: Slipping Through a Research Oversight Gap.<\/a><br \/>\nWalker RL and Fisher JA. <em>American Journal of Bioethics<\/em> 2018; 18(10): 62-63.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1513591\">Research to Promote Longevity and Health Span in Companion Dogs: A Pediatric Perspective.<\/a><br \/>\nWilfond BS, Porter KM, Creevy KE, Kaerberlein M, Promislow D. <em>American Journal of Bioethics<\/em> 2018; 18(10): 64-65.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1433798\">Involving Pregnant Women in Research: What Should We Recommend When the Regulations Seem Ethically Problematic?<\/a><br \/>\n<\/strong>Taylor HA and Morales C. <em>American Journal of Bioethics<\/em> 2018; 18(4): 91-92.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431704\">Conflicts Between Regulations and Ethical Principles: Resolving Ambiguity in Favor of the Ethically Preferable Outcome.<\/a><br \/>\nShah SK and Porter K. <em>American Journal of Bioethics<\/em> 2018; 18(4): 93-94.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431721\">When to Avoid Giving Advice on the Ethical Conduct of Research.<\/a><br \/>\nSharp RR and Allyse MA. <em>American Journal of Bioethics<\/em> 2018; 18(4): 94-95.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431706\">When Research Regulations and Ethics Conflict.<\/a><br \/>\nSullivan HK, Braverman DW, Wendler D. <em>American Journal of Bioethics<\/em> 2018; 18(4): 96-97.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1366200\">A Trial to Test a Novel Approach to Diabetes Prevention.<\/a><br \/>\n<\/strong>Taylor HA, Morales C, Wilfond BS. <em>American Journal of Bioethics<\/em> 2017; 17(10): 74-75.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365201\">Is It Ethically Acceptable to Screen Patients for Obstructive Sleep Apnea and Not Offer Them Positive Air Pressure Therapy in a Clinical Trial?<\/a><br \/>\nMcCormick JB, Wu JT, Doussau A. <em>American Journal of Bioethics<\/em> 2017; 17(10): 76-77.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365199\">Can We Breathe Easy If PAP Therapy Is Withheld?<\/a><br \/>\nTaylor HA and Punjabi NM. <em>American Journal of Bioethics<\/em> 2017; 17(10): 78-79.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1365200\">Risks of Clinical Research Must Be Reasonable and Necessary.<\/a><br \/>\nGibbes Miller D and Kim SYH. <em>American Journal of Bioethics<\/em> 2017; 17(10): 79-81.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075801\">Is It Ethical to Enroll Cognitively Impaired Adults in Research That Is More Than Minimal Risk With No Prospect of Benefit?<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(10): 64-65.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075803\">Inconsistent Approaches to Research Involving Cognitively Impaired Adults: Why the Broad View of Substituted Judgment Is Our Best Guide.<\/a><br \/>\nYarborough M. <em>American Journal of Bioethics<\/em> 2015; 15(10): 66-67.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075805\">Ethical and Regulatory Considerations Regarding Enrollment of Incompetent Adults in More Than Minimal Risk Research as Compared With Children.<\/a><br \/>\nDerse AR and Spellecy R. <em>American Journal of Bioethics<\/em> 2015; 15(10): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075806\">Acceptable Approaches to Enrolling Adults Who Cannot Consent in More Than Minimal Risk Research.<\/a><br \/>\nDanis M, Wendler D, Kim S. <em>American Journal of Bioethics<\/em> 2015; 15(10): 70-71.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011009\">Protecting Research Subject Welfare in Preventive Trials for Autosomal Dominant Alzheimer&#8217;s Disease.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(4): 83-84.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011010\">When There Are Only Two Who Can Tango: Ethical Concerns at the Juncture of Highly Novel Interventions and Precisely Targeted Research Populations.<\/a><br \/>\nYarborough M. <em>American Journal of Bioethics<\/em> 2015; 15(4): 85-86.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011012\">Conceptualization and Assessment of Vulnerability in a Complex International Alzheimer\u2019s Research Study.<\/a><br \/>\nKorenman S, Finder SG, Ringman JM. <em>American Journal of Bioethics<\/em> 2015; 15(4): 87-89.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1011013\">Barriers and Facilitators to the Consent Process in a Study of Complex Genetic Factors.<\/a><br \/>\nSimpson AR. <em>American Journal of Bioethics<\/em> 2015; 15(4): 89-90.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947806\">The Obligations to Report Statutory Sexual Abuse Disclosed in a Research Study.<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2014; 14(10): 50.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947817\">The Moral and Legal Need to Disclose Despite a Certificate of Confidentiality.<\/a><br \/>\nPaquette ET and Ross LF. <em>American Journal of Bioethics<\/em> 2014; 14(10): 51-53.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947818\">Informed Consent and the Implications for Statutory Rape Reporting in Research With Adolescents.<\/a><br \/>\nHodgkinson S, Lewin A, Chang B, Beers L, Silber T. <em>American Journal of Bioethics<\/em> 2014; 14(10): 54-55.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2014.947819\">Community, Context, and the Contrasting Roles of Clinicians and Researchers: Challenges Raised by Statutory Rape.<\/a><br \/>\nFinder SG and Korenman S. <em>American Journal of Bioethics<\/em> 2014; 14(10): 55-57.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=&#8221;Subject Selection&#8221; background_color=&#8221;#ffffff&#8221; title_color=&#8221;#ffffff&#8221;][vc_column_text]<strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1433798\">Involving Pregnant Women in Research: What Should We Recommend When the Regulations Seem Ethically Problematic?<\/a><br \/>\n<\/strong>Taylor HA and Morales C. <em>American Journal of Bioethics<\/em> 2018; 18(4): 91-92.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431704\">Conflicts Between Regulations and Ethical Principles: Resolving Ambiguity in Favor of the Ethically Preferable Outcome.<\/a><br \/>\nShah SK and Porter K. <em>American Journal of Bioethics<\/em> 2018; 18(4): 93-94.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431721\">When to Avoid Giving Advice on the Ethical Conduct of Research.<\/a><br \/>\nSharp RR and Allyse MA. <em>American Journal of Bioethics<\/em> 2018; 18(4): 94-95.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2018.1431706\">When Research Regulations and Ethics Conflict.<\/a><br \/>\nSullivan HK, Braverman DW, Wendler D. <em>American Journal of Bioethics<\/em> 2018; 18(4): 96-97.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284934\">Should Patients Be Required to Undergo Standard Chemotherapy Before Being Eligible for Novel Phase I Immunotherapy Clinical Trials?<\/a><br \/>\n<\/strong>Wilfond BS, Morales C, Taylor HA. <em>American Journal of Bioethics<\/em> 2017; 17(4): 66-67.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284922\">A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.<\/a><br \/>\nDoussau A and Hanmer CB. <em>American Journal of Bioethics<\/em> 2017; 17(4): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284933\">Participation of Citizen Scientists in Clinical Research and Access to Research Ethics Consultation.<\/a><br \/>\nCollier E and Danis M. <em>American Journal of Bioethics<\/em> 2017; 17(4): 70-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2017.1284936\">Forgoing Conventional Therapy in Phase I Oncology Research: Don&#8217;t Forget About the Children.<\/a><br \/>\nWetmore C. <em>American Journal of Bioethics<\/em> 2017; 17(4): 72-73.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1146542\">Selecting Children for an Autism Spectrum Disorder Study: Justice and Geography.<\/a><br \/>\n<\/strong><em>American Journal of Bioethics<\/em> 2016; 16(4): 69-70.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145297\">Fair Participant Selection: A Negative Obligation Not to Exclude.<\/a><br \/>\nChen SC. <em>American Journal of Bioethics<\/em> 2016; 16(4): 71-72.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145298\">Unequal Individual Risk and Potential Benefit Balanced by Benefits to the Population at Large in Autism Clinical Trials?<\/a><br \/>\nStein MA and King BH. <em>American Journal of Bioethics<\/em> 2016; 16(4): 72-74.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2016.1145303\">Justice in Selecting Participants for a Study in Phelan-McDermid Syndrome.<\/a><br \/>\nRhodes R and Kolevzon A. <em>American Journal of Bioethics<\/em> 2016; 16(4): 74-76.<\/li>\n<\/ul>\n<p><strong><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075801\">Is It Ethical to Enroll Cognitively Impaired Adults in Research That Is More Than Minimal Risk With No Prospect of Benefit?<\/a><br \/>\n<\/strong>Taylor HA, Kuwana E, Wilfond BS. <em>American Journal of Bioethics<\/em> 2015; 15(10): 64-65.<\/p>\n<ul>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075803\">Inconsistent Approaches to Research Involving Cognitively Impaired Adults: Why the Broad View of Substituted Judgment Is Our Best Guide.<\/a><br \/>\nYarborough M. <em>American Journal of Bioethics<\/em> 2015; 15(10): 66-67.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075805\">Ethical and Regulatory Considerations Regarding Enrollment of Incompetent Adults in More Than Minimal Risk Research as Compared With Children.<\/a><br \/>\nDerse AR and Spellecy R. <em>American Journal of Bioethics<\/em> 2015; 15(10): 68-69.<\/li>\n<li><a href=\"https:\/\/doi.org\/10.1080\/15265161.2015.1075806\">Acceptable Approaches to Enrolling Adults Who Cannot Consent in More Than Minimal Risk Research.<\/a><br \/>\nDanis M, Wendler D, Kim S. <em>American Journal of Bioethics<\/em> 2015; 15(10): 70-71.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_accordion_tab][\/vc_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text] \u00a0Challenging Cases [\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_column_text]Established a semi-annual series of \u201cChallenging Cases in Clinical Research Ethics\u201d in the American Journal of Bioethics.[\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row css_animation=&#8221;&#8221; row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; angled_section=&#8221;no&#8221; text_align=&#8221;left&#8221; background_image_as_pattern=&#8221;without_pattern&#8221;][vc_column][vc_accordion collapsible=&#8221;yes&#8221; style=&#8221;toggle&#8221;][vc_accordion_tab title=&#8221;All Cases&#8221;&#8230;<\/p>\n","protected":false},"author":2,"featured_media":281,"parent":295,"menu_order":20,"comment_status":"open","ping_status":"open","template":"","meta":{"footnotes":""},"class_list":["post-27","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/pages\/27","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/comments?post=27"}],"version-history":[{"count":25,"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/pages\/27\/revisions"}],"predecessor-version":[{"id":931,"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/pages\/27\/revisions\/931"}],"up":[{"embeddable":true,"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/pages\/295"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/media\/281"}],"wp:attachment":[{"href":"https:\/\/www.iths.org\/crecc\/wp-json\/wp\/v2\/media?parent=27"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}